	PMCID	SENTENCE_NUM	SENTENCE_START	SENTENCE_END	WORD	POS_TAG	WORD_START	WORD_END
0	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Targeting	VBG	0	9
1	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	IL	NNP	10	12
2	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	-	:	12	13
3	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	6	CD	13	14
4	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Is	VBZ	15	17
5	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	a	DT	18	19
6	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Potential	JJ	20	29
7	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Treatment	NN	30	39
8	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	for	IN	40	43
9	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Primary	NNP	44	51
10	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Cystic	NNP	52	58
11	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Craniopharyngioma	NNP	59	76
12	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Abstract	NNP	78	86
13	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	Adamantinomatous	NNP	88	104
14	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	craniopharyngioma	NN	105	122
15	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	(	(	123	124
16	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	ACP	NNP	124	127
17	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	)	)	127	128
18	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	makes	VBZ	129	134
19	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	up	RP	135	137
20	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	between	IN	138	145
21	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	6	CD	146	147
22	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	and	CC	148	151
23	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	8	CD	152	153
24	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	%	NN	153	154
25	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	of	IN	155	157
26	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	pediatric	JJ	158	167
27	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	brain	NN	168	173
28	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	tumors	NNS	174	180
29	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	and	CC	181	184
30	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	is	VBZ	185	187
31	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	the	DT	188	191
32	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	most	RBS	192	196
33	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	common	JJ	197	203
34	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	pediatric	JJ	204	213
35	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	tumor	NN	214	219
36	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	arising	VBG	220	227
37	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	in	IN	228	230
38	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	the	DT	231	234
39	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	sellar	JJ	235	241
40	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	/	NNP	241	242
41	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	suprasellar	JJ	242	253
42	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	region	NN	254	260
43	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	of	IN	261	263
44	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	the	DT	264	267
45	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	brain	NN	268	273
46	PMC6712354.nxml.gz	PMC6712354.nxml.gz_0	0	274	.	.	273	274
47	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	The	DT	275	278
48	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	10	CD	279	281
49	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	-	:	281	282
50	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	year	NN	282	286
51	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	survival	NN	287	295
52	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	for	IN	296	299
53	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	patients	NNS	300	308
54	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	diagnosed	VBN	309	318
55	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	with	IN	319	323
56	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	craniopharyngioma	NN	324	341
57	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	ranges	NNS	342	348
58	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	between	IN	349	356
59	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	64	CD	357	359
60	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	and	CC	360	363
61	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	92	CD	364	366
62	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	%,	NNS	366	368
63	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	but	CC	369	372
64	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	complicating	VBG	373	385
65	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	factors	NNS	386	393
66	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	such	JJ	394	398
67	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	as	IN	399	401
68	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	location	NN	402	410
69	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	,	,	410	411
70	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	common	JJ	412	418
71	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	cyst	NN	419	423
72	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	formation	NN	424	433
73	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	,	,	433	434
74	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	and	CC	435	438
75	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	potential	JJ	439	448
76	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	hypothalamic	JJ	449	461
77	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	infiltration	NN	462	474
78	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	cause	NN	475	480
79	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	significant	JJ	481	492
80	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	morbidity	NN	493	502
81	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	in	IN	503	505
82	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	this	DT	506	510
83	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	population	NN	511	521
84	PMC6712354.nxml.gz	PMC6712354.nxml.gz_1	275	522	.	.	521	522
85	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	There	EX	523	528
86	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	are	VBP	529	532
87	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	a	DT	533	534
88	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	number	NN	535	541
89	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	of	IN	542	544
90	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	therapeutic	JJ	545	556
91	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	options	NNS	557	564
92	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	for	IN	565	568
93	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	children	NNS	569	577
94	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	with	IN	578	582
95	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	ACP	NNP	583	586
96	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	,	,	586	587
97	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	including	VBG	588	597
98	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	surgery	NN	598	605
99	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	,	,	605	606
100	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	radiation	NN	607	616
101	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	,	,	616	617
102	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	and	CC	618	621
103	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	cyst	NN	622	626
104	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	directed	VBD	627	635
105	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	therapies	NNS	636	645
106	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	such	JJ	646	650
107	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	as	IN	651	653
108	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	interferon	NN	654	664
109	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	and	CC	665	668
110	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	bleomycin	NN	669	678
111	PMC6712354.nxml.gz	PMC6712354.nxml.gz_2	523	679	.	.	678	679
112	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	Research	NN	680	688
113	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	has	VBZ	689	692
114	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	raised	VBN	693	699
115	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	concerns	NNS	700	708
116	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	regarding	VBG	709	718
117	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	the	DT	719	722
118	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	efficacy	NN	723	731
119	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	and	CC	732	735
120	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	side	NN	736	740
121	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	effects	NNS	741	748
122	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	associated	VBN	749	759
123	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	with	IN	760	764
124	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	these	DT	765	770
125	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	conventional	JJ	771	783
126	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	therapies	NNS	784	793
127	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	,	,	793	794
128	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	as	RB	795	797
129	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	well	RB	798	802
130	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	as	IN	803	805
131	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	with	IN	806	810
132	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	the	DT	811	814
133	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	difficulty	NN	815	825
134	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	in	IN	826	828
135	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	treating	VBG	829	837
136	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	recurrent	JJ	838	847
137	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	cystic	JJ	848	854
138	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	ACP	NNP	855	858
139	PMC6712354.nxml.gz	PMC6712354.nxml.gz_3	680	859	.	.	858	859
140	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	Evidence	NN	860	868
141	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	from	IN	869	873
142	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	our	PRP$	874	877
143	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	group	NN	878	883
144	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	and	CC	884	887
145	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	others	NNS	888	894
146	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	has	VBZ	895	898
147	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	shown	VBN	899	904
148	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	that	IN	905	909
149	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	the	DT	910	913
150	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	cystic	JJ	914	920
151	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	and	CC	921	924
152	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	solid	JJ	925	930
153	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	tumor	NN	931	936
154	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	components	NNS	937	947
155	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	of	IN	948	950
156	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	craniopharyngioma	NNS	951	968
157	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	have	VBP	969	973
158	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	high	JJ	974	978
159	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	levels	NNS	979	985
160	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	of	IN	986	988
161	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	IL	NNP	989	991
162	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	-	:	991	992
163	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	6R	CD	992	994
164	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	and	CC	995	998
165	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	IL	NNP	999	1001
166	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	-	:	1001	1002
167	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	6	CD	1002	1003
168	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	,	,	1003	1004
169	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	providing	VBG	1005	1014
170	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	a	DT	1015	1016
171	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	potential	JJ	1017	1026
172	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	target	NN	1027	1033
173	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	for	IN	1034	1037
174	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	therapy	NN	1038	1045
175	PMC6712354.nxml.gz	PMC6712354.nxml.gz_4	860	1046	.	.	1045	1046
176	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	Tocilizumab	NNP	1047	1058
177	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	,	,	1058	1059
178	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	a	DT	1060	1061
179	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	humanized	JJ	1062	1071
180	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	monoclonal	NN	1072	1082
181	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	antibody	NN	1083	1091
182	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	,	,	1091	1092
183	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	acts	VBZ	1093	1097
184	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	against	IN	1098	1105
185	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	soluble	JJ	1106	1113
186	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	and	CC	1114	1117
187	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	membrane	NN	1118	1126
188	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	bound	NN	1127	1132
189	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	IL	NNP	1133	1135
190	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	-	:	1135	1136
191	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	6R	CD	1136	1138
192	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	,	,	1138	1139
193	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	and	CC	1140	1143
194	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	has	VBZ	1144	1147
195	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	been	VBN	1148	1152
196	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	widely	RB	1153	1159
197	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	utilized	VBN	1160	1168
198	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	in	IN	1169	1171
199	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	pediatric	JJ	1172	1181
200	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	patients	NNS	1182	1190
201	PMC6712354.nxml.gz	PMC6712354.nxml.gz_5	1047	1191	.	.	1190	1191
202	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	Two	CD	1192	1195
203	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	patients	NNS	1196	1204
204	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	with	IN	1205	1209
205	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	recurrent	JJ	1210	1219
206	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	cystic	JJ	1220	1226
207	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	ACP	NNP	1227	1230
208	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	were	VBD	1231	1235
209	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	offered	VBN	1236	1243
210	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	systemically	RB	1244	1256
211	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	administered	VBN	1257	1269
212	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	tocilizumab	NN	1270	1281
213	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	or	CC	1282	1284
214	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	a	DT	1285	1286
215	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	combination	NN	1287	1298
216	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	of	IN	1299	1301
217	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	tocilizumab	NN	1302	1313
218	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	and	CC	1314	1317
219	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	bevacizumab	NN	1318	1329
220	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	on	IN	1330	1332
221	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	a	DT	1333	1334
222	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	compassionate	NN	1335	1348
223	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	use	NN	1349	1352
224	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	basis	NN	1353	1358
225	PMC6712354.nxml.gz	PMC6712354.nxml.gz_6	1192	1359	.	.	1358	1359
226	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	Both	DT	1360	1364
227	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	patients	NNS	1365	1373
228	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	'	POS	1373	1374
229	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	tumors	NNS	1375	1381
230	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	had	VBD	1382	1385
231	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	a	DT	1386	1387
232	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	significant	JJ	1388	1399
233	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	response	NN	1400	1408
234	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	,	,	1408	1409
235	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	with	IN	1410	1414
236	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	decreased	JJ	1415	1424
237	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	cyst	NN	1425	1429
238	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	burden	NN	1430	1436
239	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	,	,	1436	1437
240	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	supporting	VBG	1438	1448
241	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	the	DT	1449	1452
242	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	assertion	NN	1453	1462
243	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	that	IN	1463	1467
244	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	tocilizumab	NN	1468	1479
245	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	with	IN	1480	1484
246	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	or	CC	1485	1487
247	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	without	IN	1488	1495
248	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	bevacizumab	NN	1496	1507
249	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	may	MD	1508	1511
250	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	be	VB	1512	1514
251	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	an	DT	1515	1517
252	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	option	NN	1518	1524
253	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	for	IN	1525	1528
254	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	patients	NNS	1529	1537
255	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	suffering	VBG	1538	1547
256	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	from	IN	1548	1552
257	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	cystic	JJ	1553	1559
258	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	ACP	NNP	1560	1563
259	PMC6712354.nxml.gz	PMC6712354.nxml.gz_7	1360	1564	.	.	1563	1564
260	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	Introduction	NNP	1566	1578
261	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	Adamantinomatous	NNP	1580	1596
262	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	craniopharyngioma	NN	1597	1614
263	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	(	(	1615	1616
264	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	ACP	NNP	1616	1619
265	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	)	)	1619	1620
266	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	is	VBZ	1621	1623
267	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	a	DT	1624	1625
268	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	neurologically	RB	1626	1640
269	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	devastating	VBG	1641	1652
270	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	chronic	JJ	1653	1660
271	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	disease	NN	1661	1668
272	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	with	IN	1669	1673
273	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	morbidity	NN	1674	1683
274	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	that	WDT	1684	1688
275	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	far	RB	1689	1692
276	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	outweighs	VBZ	1693	1702
277	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	the	DT	1703	1706
278	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	mortality	NN	1707	1716
279	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	risk	NN	1717	1721
280	PMC6712354.nxml.gz	PMC6712354.nxml.gz_8	1566	1722	.	.	1721	1722
281	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	It	PRP	1723	1725
282	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	comprises	VBZ	1726	1735
283	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	6â	CD	1736	1738
284	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843		JJ	1738	1740
285	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	8	CD	1740	1741
286	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	%	NN	1741	1742
287	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	of	IN	1743	1745
288	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	pediatric	JJ	1746	1755
289	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	brain	NN	1756	1761
290	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	tumors	NNS	1762	1768
291	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	and	CC	1769	1772
292	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	is	VBZ	1773	1775
293	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	the	DT	1776	1779
294	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	most	RBS	1780	1784
295	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	common	JJ	1785	1791
296	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	tumor	NN	1792	1797
297	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	of	IN	1798	1800
298	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	the	DT	1801	1804
299	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	sellar	JJ	1805	1811
300	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	/	NNP	1811	1812
301	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	suprasellar	JJ	1812	1823
302	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	region	NN	1824	1830
303	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	in	IN	1831	1833
304	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	children	NNS	1834	1842
305	PMC6712354.nxml.gz	PMC6712354.nxml.gz_9	1723	1843	.	.	1842	1843
306	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	ACP	NNP	1844	1847
307	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	is	VBZ	1848	1850
308	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	among	IN	1851	1856
309	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	a	DT	1857	1858
310	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	growing	VBG	1859	1866
311	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	number	NN	1867	1873
312	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	of	IN	1874	1876
313	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	pediatric	JJ	1877	1886
314	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	brain	NN	1887	1892
315	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	tumors	NNS	1893	1899
316	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	in	IN	1900	1902
317	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	which	WDT	1903	1908
318	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	tumor	NN	1909	1914
319	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	growth	NN	1915	1921
320	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	can	MD	1922	1925
321	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	often	RB	1926	1931
322	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	be	VB	1932	1934
323	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	controlled	VBN	1935	1945
324	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	with	IN	1946	1950
325	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	10	CD	1951	1953
326	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	-	:	1953	1954
327	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	year	NN	1954	1958
328	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	survival	NN	1959	1967
329	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	ranging	VBG	1968	1975
330	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	between	IN	1976	1983
331	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	64	CD	1984	1986
332	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	and	CC	1987	1990
333	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	92	CD	1991	1993
334	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	%	NN	1993	1994
335	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	however	RB	1995	2002
336	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	,	,	2002	2003
337	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	ACP	NNP	2004	2007
338	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	'	POS	2007	2008
339	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	s	NN	2008	2009
340	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	suprasellar	JJ	2010	2021
341	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	location	NN	2022	2030
342	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	and	CC	2031	2034
343	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	propensity	NN	2035	2045
344	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	for	IN	2046	2049
345	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	cyst	NN	2050	2054
346	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	formation	NN	2055	2064
347	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	[	NNP	2065	2066
348	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	present	NN	2066	2073
349	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	in	IN	2074	2076
350	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	~	JJ	2077	2078
351	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	90	CD	2078	2080
352	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	%	NN	2080	2081
353	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	]	NN	2082	2083
354	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	and	CC	2084	2087
355	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	hypothalamic	JJ	2088	2100
356	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	infiltration	NN	2101	2113
357	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	predispose	RB	2114	2124
358	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	many	JJ	2125	2129
359	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	children	NNS	2130	2138
360	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	to	TO	2139	2141
361	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	a	DT	2142	2143
362	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	life	NN	2144	2148
363	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	of	IN	2149	2151
364	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	severe	JJ	2152	2158
365	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	disability	NN	2159	2169
366	PMC6712354.nxml.gz	PMC6712354.nxml.gz_10	1844	2170	.	.	2169	2170
367	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	As	IN	2171	2173
368	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	such	JJ	2174	2178
369	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	,	,	2178	2179
370	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	ACP	NNP	2180	2183
371	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	has	VBZ	2184	2187
372	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	been	VBN	2188	2192
373	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	associated	VBN	2193	2203
374	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	with	IN	2204	2208
375	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	the	DT	2209	2212
376	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	lowest	JJS	2213	2219
377	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	quality	NN	2220	2227
378	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	of	IN	2228	2230
379	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	life	NN	2231	2235
380	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	scores	NNS	2236	2242
381	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	of	IN	2243	2245
382	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	any	DT	2246	2249
383	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	pediatric	JJ	2250	2259
384	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	brain	NN	2260	2265
385	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	tumor	NN	2266	2271
386	PMC6712354.nxml.gz	PMC6712354.nxml.gz_11	2171	2272	.	.	2271	2272
387	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	Therapeutic	JJ	2274	2285
388	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	modalities	NNS	2286	2296
389	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	for	IN	2297	2300
390	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	children	NNS	2301	2309
391	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	with	IN	2310	2314
392	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	ACP	NNP	2315	2318
393	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	include	VBP	2319	2326
394	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	maximally	RB	2327	2336
395	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	-	:	2336	2337
396	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	safe	JJ	2337	2341
397	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	surgery	NN	2342	2349
398	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	,	,	2349	2350
399	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	radiation	NN	2351	2360
400	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	,	,	2360	2361
401	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	and	CC	2362	2365
402	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	cyst	SYM	2366	2370
403	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	-	:	2370	2371
404	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	directed	JJ	2371	2379
405	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	therapies	NNS	2380	2389
406	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	,	,	2389	2390
407	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	such	JJ	2391	2395
408	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	as	IN	2396	2398
409	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	interferon	NN	2399	2409
410	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	and	CC	2410	2413
411	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	bleomycin	NN	2414	2423
412	PMC6712354.nxml.gz	PMC6712354.nxml.gz_12	2274	2424	.	.	2423	2424
413	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	None	NN	2425	2429
414	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	of	IN	2430	2432
415	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	these	DT	2433	2438
416	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	approaches	NNS	2439	2449
417	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	,	,	2449	2450
418	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	however	RB	2451	2458
419	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	,	,	2458	2459
420	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	are	VBP	2460	2463
421	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	directed	VBN	2464	2472
422	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	against	IN	2473	2480
423	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	unique	JJ	2481	2487
424	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	biological	JJ	2488	2498
425	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	characteristics	NNS	2499	2514
426	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	of	IN	2515	2517
427	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	ACP	NNP	2518	2521
428	PMC6712354.nxml.gz	PMC6712354.nxml.gz_13	2425	2522	.	.	2521	2522
429	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	Furthermore	RB	2523	2534
430	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	,	,	2534	2535
431	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	after	IN	2536	2541
432	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	many	JJ	2542	2546
433	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	years	NNS	2547	2552
434	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	of	IN	2553	2555
435	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	use	NN	2556	2559
436	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	,	,	2559	2560
437	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	each	DT	2561	2565
438	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	has	VBZ	2566	2569
439	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	been	VBN	2570	2574
440	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	shown	VBN	2575	2580
441	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	to	TO	2581	2583
442	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	be	VB	2584	2586
443	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	associated	VBN	2587	2597
444	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	with	IN	2598	2602
445	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	shortcomings	NNS	2603	2615
446	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	regarding	VBG	2616	2625
447	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	clinical	JJ	2626	2634
448	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	efficacy	NN	2635	2643
449	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	and	CC	2644	2647
450	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	/	NN	2647	2648
451	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	or	CC	2648	2650
452	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	side	NN	2651	2655
453	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	effects	NNS	2656	2663
454	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	especially	RB	2664	2674
455	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	when	WRB	2675	2679
456	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	observed	VBN	2680	2688
457	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	within	IN	2689	2695
458	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	the	DT	2696	2699
459	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	framework	NN	2700	2709
460	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	of	IN	2710	2712
461	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	ACP	NNP	2713	2716
462	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	as	IN	2717	2719
463	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	a	DT	2720	2721
464	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	chronic	JJ	2722	2729
465	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	disease	NN	2730	2737
466	PMC6712354.nxml.gz	PMC6712354.nxml.gz_14	2523	2738	.	.	2737	2738
467	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	Basic	JJ	2740	2745
468	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	science	NN	2746	2753
469	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	research	NN	2754	2762
470	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	in	IN	2763	2765
471	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	ACP	NNP	2766	2769
472	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	has	VBZ	2770	2773
473	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	demonstrated	VBN	2774	2786
474	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	a	DT	2787	2788
475	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	single	JJ	2789	2795
476	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	recurrent	NN	2796	2805
477	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	somatic	JJ	2806	2813
478	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	mutation	NN	2814	2822
479	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	of	IN	2823	2825
480	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	the	DT	2826	2829
481	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	CTNNB1	NNP	2830	2836
482	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	gene	NN	2837	2841
483	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	,	,	2841	2842
484	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	which	WDT	2843	2848
485	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	leads	VBZ	2849	2854
486	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	to	TO	2855	2857
487	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	WNT	VB	2858	2861
488	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	pathway	JJ	2862	2869
489	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	activation	NN	2870	2880
490	PMC6712354.nxml.gz	PMC6712354.nxml.gz_15	2740	2881	.	.	2880	2881
491	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	This	DT	2882	2886
492	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	mutation	NN	2887	2895
493	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	is	VBZ	2896	2898
494	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	,	,	2898	2899
495	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	unfortunately	RB	2900	2913
496	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	,	,	2913	2914
497	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	not	RB	2915	2918
498	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	currently	RB	2919	2928
499	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	therapeutically	RB	2929	2944
500	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	targetable	JJ	2945	2955
501	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	and	CC	2956	2959
502	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	is	VBZ	2960	2962
503	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	present	JJ	2963	2970
504	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	in	IN	2971	2973
505	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	a	DT	2974	2975
506	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	minority	NN	2976	2984
507	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	of	IN	2985	2987
508	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	ACP	NNP	2988	2991
509	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	cells	NNS	2992	2997
510	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	,	,	2997	2998
511	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	suggesting	VBG	2999	3009
512	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	additional	JJ	3010	3020
513	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	pathogenic	NN	3021	3031
514	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	drivers	NNS	3032	3039
515	PMC6712354.nxml.gz	PMC6712354.nxml.gz_16	2882	3040	.	.	3039	3040
516	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	Work	NN	3041	3045
517	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	using	VBG	3046	3051
518	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	recently	RB	3052	3060
519	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	developed	VBN	3061	3070
520	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	genetically	RB	3071	3082
521	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	engineered	VBN	3083	3093
522	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	mouse	NN	3094	3099
523	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	models	NNS	3100	3106
524	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	(	(	3107	3108
525	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	GEMMs	NNP	3108	3113
526	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	)	)	3113	3114
527	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	of	IN	3115	3117
528	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	ACP	NNP	3118	3121
529	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	indicates	VBZ	3122	3131
530	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	that	IN	3132	3136
531	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	the	DT	3137	3140
532	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	tumor	NN	3141	3146
533	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	arises	VBZ	3147	3153
534	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	from	IN	3154	3158
535	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	precursors	NNS	3159	3169
536	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	of	IN	3170	3172
537	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	the	DT	3173	3176
538	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	anterior	JJ	3177	3185
539	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	pituitary	JJ	3186	3195
540	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	gland	NN	3196	3201
541	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	or	CC	3202	3204
542	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	Rathke	NNP	3205	3211
543	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	'	POS	3211	3212
544	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	s	NN	3212	3213
545	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	Pouch	NNP	3214	3219
546	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	hence	NN	3220	3225
547	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	,	,	3225	3226
548	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	ACP	NNP	3227	3230
549	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	may	MD	3231	3234
550	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	not	RB	3235	3238
551	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	reside	VB	3239	3245
552	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	within	IN	3246	3252
553	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	an	DT	3253	3255
554	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	immunoprivileged	JJ	3256	3272
555	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	location	NN	3273	3281
556	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	behind	IN	3282	3288
557	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	the	DT	3289	3292
558	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	blood	NN	3293	3298
559	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	-	:	3298	3299
560	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	brain	NN	3299	3304
561	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	barrier	NN	3305	3312
562	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	[	NNP	3313	3314
563	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	BBB	NNP	3314	3317
564	PMC6712354.nxml.gz	PMC6712354.nxml.gz_17	3041	3319	].	NN	3317	3319
565	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	Further	JJ	3320	3327
566	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	work	NN	3328	3332
567	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	suggests	VBZ	3333	3341
568	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	that	IN	3342	3346
569	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	a	DT	3347	3348
570	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	unique	JJ	3349	3355
571	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	paracrine	NN	3356	3365
572	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	mechanism	NN	3366	3375
573	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	drives	VBZ	3376	3382
574	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	pathological	JJ	3383	3395
575	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	tumor	NN	3396	3401
576	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	behavior	NN	3402	3410
577	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	by	IN	3411	3413
578	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	cells	NNS	3414	3419
579	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	that	WDT	3420	3424
580	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	lack	VBP	3425	3429
581	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	the	DT	3430	3433
582	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	CTNNB1	NNP	3434	3440
583	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	mutation	NN	3441	3449
584	PMC6712354.nxml.gz	PMC6712354.nxml.gz_18	3320	3450	.	.	3449	3450
585	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	This	DT	3451	3455
586	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	assertion	NN	3456	3465
587	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	is	VBZ	3466	3468
588	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	supported	VBN	3469	3478
589	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	by	IN	3479	3481
590	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	work	NN	3482	3486
591	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	describing	VBG	3487	3497
592	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	both	CC	3498	3502
593	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	the	DT	3503	3506
594	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	pediatric	JJ	3507	3516
595	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	ACP	NNP	3517	3520
596	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	transcriptome	NN	3521	3534
597	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	and	CC	3535	3538
598	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	inflammatory	NN	3539	3551
599	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	milieu	NN	3552	3558
600	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	,	,	3558	3559
601	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	which	WDT	3560	3565
602	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	indicates	VBZ	3566	3575
603	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	a	DT	3576	3577
604	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	proinflammatory	NN	3578	3593
605	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	environment	NN	3594	3605
606	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	in	IN	3606	3608
607	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	ACP	NNP	3609	3612
608	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	tissue	NN	3613	3619
609	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	and	CC	3620	3623
610	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	cyst	NN	3624	3628
611	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	fluid	NN	3629	3634
612	PMC6712354.nxml.gz	PMC6712354.nxml.gz_19	3451	3635	.	.	3634	3635
613	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	These	DT	3636	3641
614	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	studies	NNS	3642	3649
615	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	demonstrated	VBD	3650	3662
616	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	highly	RB	3663	3669
617	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	upregulated	JJ	3670	3681
618	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	levels	NNS	3682	3688
619	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	of	IN	3689	3691
620	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	IL	NNP	3692	3694
621	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	-	:	3694	3695
622	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	6R	CD	3695	3697
623	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	and	CC	3698	3701
624	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	IL	NNP	3702	3704
625	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	-	:	3704	3705
626	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	6	CD	3705	3706
627	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	in	IN	3707	3709
628	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	cyst	NN	3710	3714
629	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	fluid	NN	3715	3720
630	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	and	CC	3721	3724
631	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	solid	JJ	3725	3730
632	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	tumor	NN	3731	3736
633	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	tissue	NN	3737	3743
634	PMC6712354.nxml.gz	PMC6712354.nxml.gz_20	3636	3744	.	.	3743	3744
635	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	While	IN	3745	3750
636	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	the	DT	3751	3754
637	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	precise	JJ	3755	3762
638	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	mechanism	NN	3763	3772
639	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	of	IN	3773	3775
640	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	paracrine	NN	3776	3785
641	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	signaling	NN	3786	3795
642	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	is	VBZ	3796	3798
643	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	not	RB	3799	3802
644	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	yet	RB	3803	3806
645	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	known	VBN	3807	3812
646	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	,	,	3812	3813
647	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	IL	NNP	3814	3816
648	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	-	:	3816	3817
649	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	6	CD	3817	3818
650	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	/	NN	3818	3819
651	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	IL	NNP	3819	3821
652	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	-	:	3821	3822
653	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	6R	CD	3822	3824
654	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	blockade	NN	3825	3833
655	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	may	MD	3834	3837
656	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	hold	VB	3838	3842
657	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	therapeutic	JJ	3843	3854
658	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	relevance	NN	3855	3864
659	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	for	IN	3865	3868
660	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	ACP	NNP	3869	3872
661	PMC6712354.nxml.gz	PMC6712354.nxml.gz_21	3745	3873	.	.	3872	3873
662	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	Tocilizumab	NNP	3875	3886
663	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	,	,	3886	3887
664	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	a	DT	3888	3889
665	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	humanized	JJ	3890	3899
666	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	monoclonal	JJ	3900	3910
667	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	antibody	NN	3911	3919
668	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	against	IN	3920	3927
669	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	soluble	JJ	3928	3935
670	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	and	CC	3936	3939
671	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	membrane	NN	3940	3948
672	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	bound	NN	3949	3954
673	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	IL	NNP	3955	3957
674	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	-	:	3957	3958
675	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	6R	CD	3958	3960
676	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	,	,	3960	3961
677	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	is	VBZ	3962	3964
678	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	approved	VBN	3965	3973
679	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	by	IN	3974	3976
680	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	the	DT	3977	3980
681	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	U	NNP	3981	3982
682	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	.	.	3982	3983
683	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	S	NNP	3983	3984
684	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	.	.	3984	3985
685	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	Food	NNP	3986	3990
686	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	and	CC	3991	3994
687	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	Drug	NNP	3995	3999
688	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	Administration	NNP	4000	4014
689	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	for	IN	4015	4018
690	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	systemic	JJ	4019	4027
691	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	administration	NN	4028	4042
692	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	in	IN	4043	4045
693	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	pediatric	JJ	4046	4055
694	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	patients	NNS	4056	4064
695	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	age	NN	4065	4068
696	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	>	VBZ	4069	4070
697	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	2	CD	4070	4071
698	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	years	NNS	4072	4077
699	PMC6712354.nxml.gz	PMC6712354.nxml.gz_22	3875	4078	.	.	4077	4078
700	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	Indications	NNS	4079	4090
701	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	include	VBP	4091	4098
702	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	the	DT	4099	4102
703	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	treatment	NN	4103	4112
704	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	of	IN	4113	4115
705	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	systemic	JJ	4116	4124
706	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	juvenile	NN	4125	4133
707	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	idiopathic	JJ	4134	4144
708	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	arthritis	NN	4145	4154
709	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	,	,	4154	4155
710	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	polyarticular	JJ	4156	4169
711	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	juvenile	NN	4170	4178
712	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	idiopathic	JJ	4179	4189
713	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	arthritis	NN	4190	4199
714	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	,	,	4199	4200
715	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	and	CC	4201	4204
716	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	cytokine	JJ	4205	4213
717	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	release	NN	4214	4221
718	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	syndrome	NN	4222	4230
719	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	following	VBG	4231	4240
720	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	chimeric	JJ	4241	4249
721	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	cntigen	NN	4250	4257
722	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	ceceptor	NN	4258	4266
723	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	(	(	4267	4268
724	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	CAR	NNP	4268	4271
725	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	)	)	4271	4272
726	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	T	NNP	4273	4274
727	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	-	:	4274	4275
728	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	cell	NN	4275	4279
729	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	therapy	NN	4280	4287
730	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	for	IN	4288	4291
731	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	acute	JJ	4292	4297
732	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	lymphoblastic	JJ	4298	4311
733	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	leukemia	NN	4312	4320
734	PMC6712354.nxml.gz	PMC6712354.nxml.gz_23	4079	4321	.	.	4320	4321
735	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	There	EX	4322	4327
736	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	is	VBZ	4328	4330
737	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	substantial	JJ	4331	4342
738	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	experience	NN	4343	4353
739	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	with	IN	4354	4358
740	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	this	DT	4359	4363
741	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	well	NN	4364	4368
742	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	-	:	4368	4369
743	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	tolerated	VBN	4369	4378
744	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	medication	NN	4379	4389
745	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	in	IN	4390	4392
746	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	the	DT	4393	4396
747	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	pediatric	JJ	4397	4406
748	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	oncology	NN	4407	4415
749	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	community	NN	4416	4425
750	PMC6712354.nxml.gz	PMC6712354.nxml.gz_24	4322	4426	.	.	4425	4426
751	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	Adverse	JJ	4427	4434
752	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	events	NNS	4435	4441
753	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	associated	VBN	4442	4452
754	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	with	IN	4453	4457
755	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	tocilizumab	NNS	4458	4469
756	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	are	VBP	4470	4473
757	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	infection	NN	4474	4483
758	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	,	,	4483	4484
759	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	neutropenia	NN	4485	4496
760	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	,	,	4496	4497
761	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	thrombocytopenia	NN	4498	4514
762	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	,	,	4514	4515
763	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	and	CC	4516	4519
764	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	elevated	VBD	4520	4528
765	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	liver	RB	4529	4534
766	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	enzymes	RB	4535	4542
767	PMC6712354.nxml.gz	PMC6712354.nxml.gz_25	4427	4543	.	.	4542	4543
768	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	This	DT	4544	4548
769	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	report	NN	4549	4555
770	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	discusses	VBZ	4556	4565
771	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	the	DT	4566	4569
772	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	management	NN	4570	4580
773	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	of	IN	4581	4583
774	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	two	CD	4584	4587
775	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	patients	NNS	4588	4596
776	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	with	IN	4597	4601
777	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	cystic	JJ	4602	4608
778	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	ACP	NNP	4609	4612
779	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	who	WP	4613	4616
780	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	failed	VBD	4617	4623
781	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	first	RB	4624	4629
782	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	line	NN	4630	4634
783	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	cystic	JJ	4635	4641
784	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	-	:	4641	4642
785	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	directed	JJ	4642	4650
786	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	therapies	NNS	4651	4660
787	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	and	CC	4661	4664
788	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	were	VBD	4665	4669
789	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	eventually	RB	4670	4680
790	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	offered	VBN	4681	4688
791	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	systemic	JJ	4689	4697
792	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	administration	NN	4698	4712
793	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	of	IN	4713	4715
794	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	the	DT	4716	4719
795	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	IL	NNP	4720	4722
796	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	-	:	4722	4723
797	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	6R	CD	4723	4725
798	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	antibody	NN	4726	4734
799	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	,	,	4734	4735
800	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	tocilizumab	NN	4736	4747
801	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	,	,	4747	4748
802	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	on	IN	4749	4751
803	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	a	DT	4752	4753
804	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	compassionate	NN	4754	4767
805	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	use	NN	4768	4771
806	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	basis	NN	4772	4777
807	PMC6712354.nxml.gz	PMC6712354.nxml.gz_26	4544	4778	.	.	4777	4778
808	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	Primary	JJ	4780	4787
809	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	patient	NN	4788	4795
810	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	samples	NNS	4796	4803
811	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	were	VBD	4804	4808
812	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	obtained	VBN	4809	4817
813	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	from	IN	4818	4822
814	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	Children	NNP	4823	4831
815	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	'	POS	4831	4832
816	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	s	NN	4832	4833
817	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	Hospital	NNP	4834	4842
818	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	Colorado	NNP	4843	4851
819	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	and	CC	4852	4855
820	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	collected	VBN	4856	4865
821	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	in	IN	4866	4868
822	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	accordance	NN	4869	4879
823	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	with	IN	4880	4884
824	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	local	JJ	4885	4890
825	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	and	CC	4891	4894
826	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	Federal	NNP	4895	4902
827	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	human	NNP	4903	4908
828	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	research	NN	4909	4917
829	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	protection	NN	4918	4928
830	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	guidelines	NNS	4929	4939
831	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	and	CC	4940	4943
832	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	institutional	JJ	4944	4957
833	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	review	NN	4958	4964
834	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	board	NN	4965	4970
835	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	regulations	NNS	4971	4982
836	PMC6712354.nxml.gz	PMC6712354.nxml.gz_27	4780	4983	.	.	4982	4983
837	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	The	DT	4984	4987
838	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	protocol	NN	4988	4996
839	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	was	VBD	4997	5000
840	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	approved	VBN	5001	5009
841	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	by	IN	5010	5012
842	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	the	DT	5013	5016
843	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	Colorado	NNP	5017	5025
844	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	Multiple	NNP	5026	5034
845	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	Institutional	NNP	5035	5048
846	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	Review	NNP	5049	5055
847	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	Board	NNP	5056	5061
848	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	(	(	5062	5063
849	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	COMIRB	NNP	5063	5069
850	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	95â	CD	5070	5073
851	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080		VBD	5073	5075
852	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	500	CD	5075	5078
853	PMC6712354.nxml.gz	PMC6712354.nxml.gz_28	4984	5080	).	NN	5078	5080
854	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	Written	NNP	5081	5088
855	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	informed	VBD	5089	5097
856	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	consent	NN	5098	5105
857	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	was	VBD	5106	5109
858	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	obtained	VBN	5110	5118
859	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	for	IN	5119	5122
860	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	all	DT	5123	5126
861	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	specimens	NNS	5127	5136
862	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	and	CC	5137	5140
863	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	clinical	JJ	5141	5149
864	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	information	NN	5150	5161
865	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	collected	VBN	5162	5171
866	PMC6712354.nxml.gz	PMC6712354.nxml.gz_29	5081	5172	.	.	5171	5172
867	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	Case	NNP	5174	5178
868	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	1	CD	5179	5180
869	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	Presentation	NNP	5181	5193
870	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	A	NNP	5195	5196
871	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	3	CD	5197	5198
872	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	-	:	5198	5199
873	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	year	NN	5199	5203
874	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	-	:	5203	5204
875	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	old	JJ	5204	5207
876	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	male	NN	5208	5212
877	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	presented	VBN	5213	5222
878	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	to	TO	5223	5225
879	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	the	DT	5226	5229
880	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	Emergency	NNP	5230	5239
881	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	Department	NNP	5240	5250
882	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	after	IN	5251	5256
883	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	hitting	VBG	5257	5264
884	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	his	PRP$	5265	5268
885	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	head	NN	5269	5273
886	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	during	IN	5274	5280
887	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	a	DT	5281	5282
888	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	fall	NN	5283	5287
889	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	from	IN	5288	5292
890	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	a	DT	5293	5294
891	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	crib	NN	5295	5299
892	PMC6712354.nxml.gz	PMC6712354.nxml.gz_30	5174	5300	.	.	5299	5300
893	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	CT	NNP	5301	5303
894	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	scan	JJ	5304	5308
895	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	revealed	VBD	5309	5317
896	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	a	DT	5318	5319
897	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	suprasellar	JJ	5320	5331
898	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	mass	NN	5332	5336
899	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	with	IN	5337	5341
900	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	extensive	JJ	5342	5351
901	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	cysts	NNS	5352	5357
902	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	extending	VBG	5358	5367
903	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	throughout	IN	5368	5378
904	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	the	DT	5379	5382
905	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	right	JJ	5383	5388
906	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	middle	NN	5389	5395
907	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	and	CC	5396	5399
908	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	bilateral	JJ	5400	5409
909	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	posterior	JJ	5410	5419
910	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	cranial	JJ	5420	5427
911	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	fossae	NN	5428	5434
912	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	,	,	5434	5435
913	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	as	RB	5436	5438
914	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	well	RB	5439	5443
915	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	as	IN	5444	5446
916	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	to	TO	5447	5449
917	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	the	DT	5450	5453
918	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	atrium	NN	5454	5460
919	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	of	IN	5461	5463
920	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	the	DT	5464	5467
921	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	right	JJ	5468	5473
922	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	lateral	JJ	5474	5481
923	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	ventricle	NN	5482	5491
924	PMC6712354.nxml.gz	PMC6712354.nxml.gz_31	5301	5492	.	.	5491	5492
925	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	MRI	NNP	5493	5496
926	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	(	(	5497	5498
927	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	Figure	NNP	5498	5504
928	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	1A	CD	5505	5507
929	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	)	)	5507	5508
930	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	confirmed	VBD	5509	5518
931	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	the	DT	5519	5522
932	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	findings	NNS	5523	5531
933	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	,	,	5531	5532
934	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	which	WDT	5533	5538
935	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	were	VBD	5539	5543
936	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	most	RBS	5544	5548
937	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	consistent	JJ	5549	5559
938	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	with	IN	5560	5564
939	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	the	DT	5565	5568
940	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	diagnosis	NN	5569	5578
941	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	of	IN	5579	5581
942	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	craniopharyngioma	NN	5582	5599
943	PMC6712354.nxml.gz	PMC6712354.nxml.gz_32	5493	5600	.	.	5599	5600
944	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	MRI	NNP	5601	5604
945	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	-	:	5604	5605
946	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	based	VBN	5605	5610
947	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	manual	JJ	5611	5617
948	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	segmentation	NN	5618	5630
949	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	software	NN	5631	5639
950	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	Aquarius	NNP	5640	5648
951	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	(	(	5649	5650
952	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	iNtuition	NN	5650	5659
953	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	,	,	5659	5660
954	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	TeraRecon	NNP	5661	5670
955	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	,	,	5670	5671
956	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	Forest	NNP	5672	5678
957	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	City	NNP	5679	5683
958	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	,	,	5683	5684
959	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	CA	NNP	5685	5687
960	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	)	)	5687	5688
961	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	was	VBD	5689	5692
962	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	used	VBN	5693	5697
963	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	to	TO	5698	5700
964	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	measure	VB	5701	5708
965	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	tumor	NN	5709	5714
966	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	volumes	NNS	5715	5722
967	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	showing	VBG	5723	5730
968	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	primary	JJ	5731	5738
969	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	cystic	JJ	5739	5745
970	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	disease	NN	5746	5753
971	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	with	IN	5754	5758
972	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	minimal	JJ	5759	5766
973	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	solid	JJ	5767	5772
974	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	tumor	NN	5773	5778
975	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	component	NN	5779	5788
976	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	(	(	5789	5790
977	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	Figure	NNP	5790	5796
978	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	1	CD	5797	5798
979	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	,	,	5798	5799
980	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	graph	NN	5800	5805
981	PMC6712354.nxml.gz	PMC6712354.nxml.gz_33	5601	5807	).	NN	5805	5807
982	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	The	DT	5808	5811
983	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	patient	NN	5812	5819
984	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	'	POS	5819	5820
985	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	s	JJ	5820	5821
986	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	medical	JJ	5822	5829
987	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	history	NN	5830	5837
988	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	included	VBD	5838	5846
989	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	premature	JJ	5847	5856
990	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	birth	NN	5857	5862
991	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	at	IN	5863	5865
992	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	34	CD	5866	5868
993	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	weeks	NNS	5869	5874
994	PMC6712354.nxml.gz	PMC6712354.nxml.gz_34	5808	5875	.	.	5874	5875
995	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	He	PRP	5876	5878
996	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	demonstrated	VBD	5879	5891
997	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	normal	JJ	5892	5898
998	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	growth	NN	5899	5905
999	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	and	CC	5906	5909
1000	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	development	NN	5910	5921
1001	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	until	IN	5922	5927
1002	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	13	CD	5928	5930
1003	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	months	NNS	5931	5937
1004	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	of	IN	5938	5940
1005	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	age	NN	5941	5944
1006	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	when	WRB	5945	5949
1007	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	he	PRP	5950	5952
1008	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	experienced	VBD	5953	5964
1009	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	speech	NN	5965	5971
1010	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	and	CC	5972	5975
1011	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	motor	NN	5976	5981
1012	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	regression	NN	5982	5992
1013	PMC6712354.nxml.gz	PMC6712354.nxml.gz_35	5876	5993	.	.	5992	5993
1014	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	He	PRP	5994	5996
1015	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	regained	VBD	5997	6005
1016	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	some	DT	6006	6010
1017	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	motor	NN	6011	6016
1018	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	skills	NNS	6017	6023
1019	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	prior	RB	6024	6029
1020	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	to	TO	6030	6032
1021	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	his	PRP$	6033	6036
1022	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	presentation	NN	6037	6049
1023	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	but	CC	6050	6053
1024	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	continued	VBD	6054	6063
1025	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	to	TO	6064	6066
1026	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	experience	VB	6067	6077
1027	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	mild	NN	6078	6082
1028	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	to	TO	6083	6085
1029	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	moderate	VB	6086	6094
1030	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	speech	NN	6095	6101
1031	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	delay	NN	6102	6107
1032	PMC6712354.nxml.gz	PMC6712354.nxml.gz_36	5994	6108	.	.	6107	6108
1033	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	Caption	NNP	6110	6117
1034	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	(	(	6118	6119
1035	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	Fig	NNP	6119	6122
1036	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	):	NNP	6122	6124
1037	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	FIG	NNP	6125	6128
1038	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	1	CD	6129	6130
1039	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	Cyst	NNP	6132	6136
1040	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	volume	NN	6137	6143
1041	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	(	(	6144	6145
1042	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	cm3	NN	6145	6148
1043	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	)	)	6148	6149
1044	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	in	IN	6150	6152
1045	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	response	NN	6153	6161
1046	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	to	TO	6162	6164
1047	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	treatment	NN	6165	6174
1048	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	course	NN	6175	6181
1049	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	for	IN	6182	6185
1050	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	patient	JJ	6186	6193
1051	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	1	CD	6194	6195
1052	PMC6712354.nxml.gz	PMC6712354.nxml.gz_37	6110	6196	.	.	6195	6196
1053	PMC6712354.nxml.gz	PMC6712354.nxml.gz_38	6197	6217	(	(	6197	6198
1054	PMC6712354.nxml.gz	PMC6712354.nxml.gz_38	6197	6217	A	DT	6198	6199
1055	PMC6712354.nxml.gz	PMC6712354.nxml.gz_38	6197	6217	)	)	6199	6200
1056	PMC6712354.nxml.gz	PMC6712354.nxml.gz_38	6197	6217	Diagnostic	NNP	6201	6211
1057	PMC6712354.nxml.gz	PMC6712354.nxml.gz_38	6197	6217	MRis	NNP	6212	6216
1058	PMC6712354.nxml.gz	PMC6712354.nxml.gz_38	6197	6217	.	.	6216	6217
1059	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	(	(	6218	6219
1060	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	B	NNP	6219	6220
1061	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	)	)	6220	6221
1062	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	Early	JJ	6222	6227
1063	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	response	NN	6228	6236
1064	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	to	TO	6237	6239
1065	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	interferon	VB	6240	6250
1066	PMC6712354.nxml.gz	PMC6712354.nxml.gz_39	6218	6251	.	.	6250	6251
1067	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	(	(	6252	6253
1068	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	C	NNP	6253	6254
1069	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	)	)	6254	6255
1070	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	Response	NNP	6256	6264
1071	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	at	IN	6265	6267
1072	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	end	NN	6268	6271
1073	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	of	IN	6272	6274
1074	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	bleomycin	NN	6275	6284
1075	PMC6712354.nxml.gz	PMC6712354.nxml.gz_40	6252	6285	.	.	6284	6285
1076	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	(	(	6286	6287
1077	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	D	NNP	6287	6288
1078	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	)	)	6288	6289
1079	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	Best	JJS	6290	6294
1080	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	response	NN	6295	6303
1081	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	to	TO	6304	6306
1082	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	tocilizumab	VB	6307	6318
1083	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	alone	RB	6319	6324
1084	PMC6712354.nxml.gz	PMC6712354.nxml.gz_41	6286	6325	.	.	6324	6325
1085	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	(	(	6326	6327
1086	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	E	NN	6327	6328
1087	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	)	)	6328	6329
1088	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	Best	JJS	6330	6334
1089	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	response	NN	6335	6343
1090	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	to	TO	6344	6346
1091	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	tocilizumab	VB	6347	6358
1092	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	and	CC	6359	6362
1093	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	bevacizumab	VB	6363	6374
1094	PMC6712354.nxml.gz	PMC6712354.nxml.gz_42	6326	6375	.	.	6374	6375
1095	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	(	(	6376	6377
1096	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	F	NNP	6377	6378
1097	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	)	)	6378	6379
1098	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	Six	NNP	6380	6383
1099	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	months	NNS	6384	6390
1100	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	off	IN	6391	6394
1101	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	all	DT	6395	6398
1102	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	therapy	NN	6399	6406
1103	PMC6712354.nxml.gz	PMC6712354.nxml.gz_43	6376	6407	.	.	6406	6407
1104	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	(	(	6408	6409
1105	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	G	NNP	6409	6410
1106	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	)	)	6410	6411
1107	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	Most	JJS	6412	6416
1108	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	recent	JJ	6417	6423
1109	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	scan	NN	6424	6428
1110	PMC6712354.nxml.gz	PMC6712354.nxml.gz_44	6408	6429	.	.	6428	6429
1111	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	(	(	6430	6431
1112	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	H	NNP	6431	6432
1113	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	)	)	6432	6433
1114	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	Cyst	NNP	6434	6438
1115	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	volume	NN	6439	6445
1116	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	(	(	6446	6447
1117	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	cm3	NN	6447	6450
1118	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	)	)	6450	6451
1119	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	in	IN	6452	6454
1120	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	response	NN	6455	6463
1121	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	to	TO	6464	6466
1122	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	treatment	NN	6467	6476
1123	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	course	NN	6477	6483
1124	PMC6712354.nxml.gz	PMC6712354.nxml.gz_45	6430	6484	.	.	6483	6484
1125	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	A	DT	6486	6487
1126	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	cyst	NN	6488	6492
1127	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	catheter	NN	6493	6501
1128	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	was	VBD	6502	6505
1129	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	placed	VBN	6506	6512
1130	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	into	IN	6513	6517
1131	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	the	DT	6518	6521
1132	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	dominant	JJ	6522	6530
1133	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	right	JJ	6531	6536
1134	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	temporal	JJ	6537	6545
1135	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	cyst	NN	6546	6550
1136	PMC6712354.nxml.gz	PMC6712354.nxml.gz_46	6486	6551	.	.	6550	6551
1137	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	Three	CD	6552	6557
1138	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	days	NNS	6558	6562
1139	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	after	IN	6563	6568
1140	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	discharge	NN	6569	6578
1141	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	,	,	6578	6579
1142	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	he	PRP	6580	6582
1143	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	developed	VBD	6583	6592
1144	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	significant	JJ	6593	6604
1145	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	facial	JJ	6605	6611
1146	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	and	CC	6612	6615
1147	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	scalp	JJ	6616	6621
1148	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	swelling	VBG	6622	6630
1149	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	accompanied	VBN	6631	6642
1150	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	by	IN	6643	6645
1151	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	vomiting	VBG	6646	6654
1152	PMC6712354.nxml.gz	PMC6712354.nxml.gz_47	6552	6655	.	.	6654	6655
1153	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	This	DT	6656	6660
1154	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	swelling	NN	6661	6669
1155	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	was	VBD	6670	6673
1156	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	ultimately	RB	6674	6684
1157	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	attributed	VBN	6685	6695
1158	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	to	TO	6696	6698
1159	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	cyst	VB	6699	6703
1160	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	fluid	JJ	6704	6709
1161	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	tracking	VBG	6710	6718
1162	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	along	IN	6719	6724
1163	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	the	DT	6725	6728
1164	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	outside	NN	6729	6736
1165	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	of	IN	6737	6739
1166	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	the	DT	6740	6743
1167	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	catheter	NN	6744	6752
1168	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	and	CC	6753	6756
1169	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	under	IN	6757	6762
1170	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	the	DT	6763	6766
1171	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	Ommaya	NNP	6767	6773
1172	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	reservoir	NN	6774	6783
1173	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	into	IN	6784	6788
1174	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	the	DT	6789	6792
1175	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	subcutaneous	JJ	6793	6805
1176	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	soft	JJ	6806	6810
1177	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	tissues	NNS	6811	6818
1178	PMC6712354.nxml.gz	PMC6712354.nxml.gz_48	6656	6819	.	.	6818	6819
1179	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	He	PRP	6820	6822
1180	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	was	VBD	6823	6826
1181	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	successfully	RB	6827	6839
1182	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	treated	VBN	6840	6847
1183	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	with	IN	6848	6852
1184	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	a	DT	6853	6854
1185	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	course	NN	6855	6861
1186	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	of	IN	6862	6864
1187	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	oral	JJ	6865	6869
1188	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	dexamethasone	NN	6870	6883
1189	PMC6712354.nxml.gz	PMC6712354.nxml.gz_49	6820	6884	.	.	6883	6884
1190	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	Approximately	RB	6886	6899
1191	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	6	CD	6900	6901
1192	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	weeks	NNS	6902	6907
1193	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	following	VBG	6908	6917
1194	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	placement	NN	6918	6927
1195	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	,	,	6927	6928
1196	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	he	PRP	6929	6931
1197	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	was	VBD	6932	6935
1198	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	treated	VBN	6936	6943
1199	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	with	IN	6944	6948
1200	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	intracystic	JJ	6949	6960
1201	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	IFN	NNP	6961	6964
1202	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	-	:	6964	6965
1203	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	Î	NN	6965	6966
1204	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	±	NN	6966	6967
1205	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	according	VBG	6968	6977
1206	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	to	TO	6978	6980
1207	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	previously	RB	6981	6991
1208	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	utilized	JJ	6992	7000
1209	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	protocols	NNS	7001	7010
1210	PMC6712354.nxml.gz	PMC6712354.nxml.gz_50	6886	7011	.	.	7010	7011
1211	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	Overall	JJ	7012	7019
1212	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	cyst	NN	7020	7024
1213	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	volume	NN	7025	7031
1214	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	initially	RB	7032	7041
1215	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	decreased	VBD	7042	7051
1216	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	(	(	7052	7053
1217	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	Figure	NNP	7053	7059
1218	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	1B	CD	7060	7062
1219	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	)	)	7062	7063
1220	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	however	RB	7064	7071
1221	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	,	,	7071	7072
1222	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	after	IN	7073	7078
1223	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	4	CD	7079	7080
1224	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	months	NNS	7081	7087
1225	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	of	IN	7088	7090
1226	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	therapy	NN	7091	7098
1227	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	,	,	7098	7099
1228	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	the	DT	7100	7103
1229	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	cystic	JJ	7104	7110
1230	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	component	NN	7111	7120
1231	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	began	VBD	7121	7126
1232	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	to	TO	7127	7129
1233	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	increase	VB	7130	7138
1234	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	in	IN	7139	7141
1235	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	size	NN	7142	7146
1236	PMC6712354.nxml.gz	PMC6712354.nxml.gz_51	7012	7147	.	.	7146	7147
1237	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	The	DT	7148	7151
1238	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	patient	NN	7152	7159
1239	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	was	VBD	7160	7163
1240	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	transitioned	VBN	7164	7176
1241	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	to	TO	7177	7179
1242	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	intracystic	JJ	7180	7191
1243	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	bleomycin	NN	7192	7201
1244	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	therapy	NN	7202	7209
1245	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	and	CC	7210	7213
1246	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	received	VBD	7214	7222
1247	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	3	CD	7223	7224
1248	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	units	NNS	7225	7230
1249	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	/	VBD	7230	7231
1250	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	10	CD	7231	7233
1251	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	mls	NN	7234	7237
1252	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	three	CD	7238	7243
1253	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	times	NNS	7244	7249
1254	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	per	IN	7250	7253
1255	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	week	NN	7254	7258
1256	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	for	IN	7259	7262
1257	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	a	DT	7263	7264
1258	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	total	NN	7265	7270
1259	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	of	IN	7271	7273
1260	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	14	CD	7274	7276
1261	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	doses	NNS	7277	7282
1262	PMC6712354.nxml.gz	PMC6712354.nxml.gz_52	7148	7283	.	.	7282	7283
1263	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	Following	VBG	7285	7294
1264	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	5	CD	7295	7296
1265	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	weeks	NNS	7297	7302
1266	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	of	IN	7303	7305
1267	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	intracystic	JJ	7306	7317
1268	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	bleomycin	NN	7318	7327
1269	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	,	,	7327	7328
1270	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	he	PRP	7329	7331
1271	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	presented	VBD	7332	7341
1272	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	emergently	RB	7342	7352
1273	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	with	IN	7353	7357
1274	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	new	JJ	7358	7361
1275	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	onset	NN	7362	7367
1276	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	left	VBD	7368	7372
1277	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	VI	NNP	7373	7375
1278	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	and	CC	7376	7379
1279	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	VII	NNP	7380	7383
1280	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	cranial	JJ	7384	7391
1281	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	nerve	NN	7392	7397
1282	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	palsies	NNS	7398	7405
1283	PMC6712354.nxml.gz	PMC6712354.nxml.gz_53	7285	7406	.	.	7405	7406
1284	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	MRI	NNP	7407	7410
1285	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	demonstrated	VBD	7411	7423
1286	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	new	JJ	7424	7427
1287	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	edema	NN	7428	7433
1288	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	involving	VBG	7434	7443
1289	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	the	DT	7444	7447
1290	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	left	NN	7448	7452
1291	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	pons	NNS	7453	7457
1292	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	,	,	7457	7458
1293	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	middle	JJ	7459	7465
1294	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	cerebellar	JJ	7466	7476
1295	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	peduncle	NN	7477	7485
1296	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	,	,	7485	7486
1297	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	and	CC	7487	7490
1298	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	anterior	RB	7491	7499
1299	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	right	JJ	7500	7505
1300	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	cerebellar	NN	7506	7516
1301	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	hemisphere	RB	7517	7527
1302	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	,	,	7527	7528
1303	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	in	IN	7529	7531
1304	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	continuity	NN	7532	7542
1305	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	with	IN	7543	7547
1306	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	one	CD	7548	7551
1307	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	wall	NN	7552	7556
1308	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	of	IN	7557	7559
1309	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	the	DT	7560	7563
1310	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	cyst	NN	7564	7568
1311	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	receiving	VBG	7569	7578
1312	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	bleomycin	NN	7579	7588
1313	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	(	(	7589	7590
1314	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	Figure	NNP	7590	7596
1315	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	1C	CD	7597	7599
1316	PMC6712354.nxml.gz	PMC6712354.nxml.gz_54	7407	7601	).	NN	7599	7601
1317	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	Bleomycin	NNP	7602	7611
1318	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	therapy	NN	7612	7619
1319	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	was	VBD	7620	7623
1320	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	discontinued	VBN	7624	7636
1321	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	,	,	7636	7637
1322	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	and	CC	7638	7641
1323	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	the	DT	7642	7645
1324	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	patient	NN	7646	7653
1325	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	was	VBD	7654	7657
1326	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	treated	VBN	7658	7665
1327	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	with	IN	7666	7670
1328	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	dexamethasone	NN	7671	7684
1329	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	,	,	7684	7685
1330	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	resulting	VBG	7686	7695
1331	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	in	IN	7696	7698
1332	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	full	JJ	7699	7703
1333	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	recovery	NN	7704	7712
1334	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	of	IN	7713	7715
1335	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	CN	NNP	7716	7718
1336	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	VI	NNP	7719	7721
1337	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	and	CC	7722	7725
1338	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	partial	JJ	7726	7733
1339	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	recovery	NN	7734	7742
1340	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	of	IN	7743	7745
1341	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	CN	NNP	7746	7748
1342	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	VII	NNP	7749	7752
1343	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	function	NN	7753	7761
1344	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	,	,	7761	7762
1345	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	with	IN	7763	7767
1346	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	residual	JJ	7768	7776
1347	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	mild	JJ	7777	7781
1348	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	facial	JJ	7782	7788
1349	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	asymmetry	NN	7789	7798
1350	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	and	CC	7799	7802
1351	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	weakness	NN	7803	7811
1352	PMC6712354.nxml.gz	PMC6712354.nxml.gz_55	7602	7812	.	.	7811	7812
1353	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	The	DT	7814	7817
1354	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	patient	NN	7818	7825
1355	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	remained	VBD	7826	7834
1356	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	off	IN	7835	7838
1357	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	of	IN	7839	7841
1358	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	therapy	NN	7842	7849
1359	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	with	IN	7850	7854
1360	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	routine	JJ	7855	7862
1361	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	MRI	NNP	7863	7866
1362	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	scanning	NN	7867	7875
1363	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	to	TO	7876	7878
1364	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	monitor	VB	7879	7886
1365	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	for	IN	7887	7890
1366	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	disease	NN	7891	7898
1367	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	progression	NN	7899	7910
1368	PMC6712354.nxml.gz	PMC6712354.nxml.gz_56	7814	7911	.	.	7910	7911
1369	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	During	IN	7912	7918
1370	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	the	DT	7919	7922
1371	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	initial	JJ	7923	7930
1372	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	7	CD	7931	7932
1373	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	months	NNS	7933	7939
1374	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	,	,	7939	7940
1375	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	there	EX	7941	7946
1376	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	was	VBD	7947	7950
1377	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	radiographic	JJ	7951	7963
1378	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	improvement	NN	7964	7975
1379	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	of	IN	7976	7978
1380	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	the	DT	7979	7982
1381	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	cystic	JJ	7983	7989
1382	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	portions	NNS	7990	7998
1383	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	of	IN	7999	8001
1384	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	his	PRP$	8002	8005
1385	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	lesion	NN	8006	8012
1386	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	however	RB	8013	8020
1387	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	,	,	8020	8021
1388	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	imaging	VBG	8022	8029
1389	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	at	IN	8030	8032
1390	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	14	CD	8033	8035
1391	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	months	NNS	8036	8042
1392	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	off	IN	8043	8046
1393	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	therapy	NN	8047	8054
1394	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	demonstrated	VBD	8055	8067
1395	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	progression	NN	8068	8079
1396	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	of	IN	8080	8082
1397	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	his	PRP$	8083	8086
1398	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	cystic	JJ	8087	8093
1399	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	disease	NN	8094	8101
1400	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	(	(	8102	8103
1401	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	Figure	NNP	8103	8109
1402	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	1	CD	8110	8111
1403	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	,	,	8111	8112
1404	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	graph	NN	8113	8118
1405	PMC6712354.nxml.gz	PMC6712354.nxml.gz_57	7912	8120	).	NN	8118	8120
1406	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	Given	VBN	8122	8127
1407	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	his	PRP$	8128	8131
1408	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	young	JJ	8132	8137
1409	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	age	NN	8138	8141
1410	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	and	CC	8142	8145
1411	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	the	DT	8146	8149
1412	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	large	JJ	8150	8155
1413	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	potential	JJ	8156	8165
1414	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	radiation	NN	8166	8175
1415	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	field	NN	8176	8181
1416	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	,	,	8181	8182
1417	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	the	DT	8183	8186
1418	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	risks	NNS	8187	8192
1419	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	of	IN	8193	8195
1420	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	radiation	NN	8196	8205
1421	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	therapy	NN	8206	8213
1422	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	were	VBD	8214	8218
1423	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	thought	VBN	8219	8226
1424	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	to	TO	8227	8229
1425	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	outweigh	VB	8230	8238
1426	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	the	DT	8239	8242
1427	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	benefit	NN	8243	8250
1428	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	,	,	8250	8251
1429	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	and	CC	8252	8255
1430	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	he	PRP	8256	8258
1431	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	was	VBD	8259	8262
1432	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	offered	VBN	8263	8270
1433	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	treatment	NN	8271	8280
1434	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	with	IN	8281	8285
1435	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	tociliziumab	NN	8286	8298
1436	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	(	(	8299	8300
1437	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	12	CD	8300	8302
1438	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	mg	NN	8303	8305
1439	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	/	NNP	8305	8306
1440	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	kg	NNP	8306	8308
1441	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	IV	NNP	8309	8311
1442	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	q2	NNP	8312	8314
1443	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	weeks	NNS	8315	8320
1444	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	)	)	8320	8321
1445	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	on	IN	8322	8324
1446	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	a	DT	8325	8326
1447	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	compassionate	NN	8327	8340
1448	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	use	NN	8341	8344
1449	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	basis	NN	8345	8350
1450	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	,	,	8350	8351
1451	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	which	WDT	8352	8357
1452	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	he	PRP	8358	8360
1453	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	received	VBD	8361	8369
1454	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	for	IN	8370	8373
1455	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	6	CD	8374	8375
1456	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	months	NNS	8376	8382
1457	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	and	CC	8383	8386
1458	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	tolerated	VBN	8387	8396
1459	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	well	RB	8397	8401
1460	PMC6712354.nxml.gz	PMC6712354.nxml.gz_58	8122	8402	.	.	8401	8402
1461	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	Imaging	VBG	8403	8410
1462	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	6	CD	8411	8412
1463	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	months	NNS	8413	8419
1464	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	following	VBG	8420	8429
1465	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	the	DT	8430	8433
1466	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	start	NN	8434	8439
1467	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	of	IN	8440	8442
1468	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	therapy	NN	8443	8450
1469	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	demonstrated	VBD	8451	8463
1470	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	a	DT	8464	8465
1471	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	decrease	NN	8466	8474
1472	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	in	IN	8475	8477
1473	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	volume	NN	8478	8484
1474	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	of	IN	8485	8487
1475	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	some	DT	8488	8492
1476	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	cysts	NNS	8493	8498
1477	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	and	CC	8499	8502
1478	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	an	DT	8503	8505
1479	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	apparent	JJ	8506	8514
1480	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	slowing	NN	8515	8522
1481	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	of	IN	8523	8525
1482	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	expansion	NN	8526	8535
1483	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	of	IN	8536	8538
1484	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	others	NNS	8539	8545
1485	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	(	(	8546	8547
1486	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	Figure	NN	8547	8553
1487	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	1D	CD	8554	8556
1488	PMC6712354.nxml.gz	PMC6712354.nxml.gz_59	8403	8558	).	NN	8556	8558
1489	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	Following	VBG	8559	8568
1490	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	an	DT	8569	8571
1491	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	additional	JJ	8572	8582
1492	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	3	CD	8583	8584
1493	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	months	NNS	8585	8591
1494	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	of	IN	8592	8594
1495	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	therapy	NN	8595	8602
1496	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	,	,	8602	8603
1497	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	the	DT	8604	8607
1498	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	patient	NN	8608	8615
1499	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	was	VBD	8616	8619
1500	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	admitted	VBN	8620	8628
1501	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	to	TO	8629	8631
1502	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	the	DT	8632	8635
1503	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	Emergency	NNP	8636	8645
1504	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	Department	NNP	8646	8656
1505	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	for	IN	8657	8660
1506	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	seizure	NN	8661	8668
1507	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	episodes	NNS	8669	8677
1508	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	coincident	NN	8678	8688
1509	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	with	IN	8689	8693
1510	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	the	DT	8694	8697
1511	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	collapse	NN	8698	8706
1512	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	of	IN	8707	8709
1513	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	multiple	JJ	8710	8718
1514	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	cysts	NNS	8719	8724
1515	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	,	,	8724	8725
1516	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	although	IN	8726	8734
1517	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	it	PRP	8735	8737
1518	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	could	MD	8738	8743
1519	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	not	RB	8744	8747
1520	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	be	VB	8748	8750
1521	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	definitively	RB	8751	8763
1522	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	determined	VBN	8764	8774
1523	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	that	IN	8775	8779
1524	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	the	DT	8780	8783
1525	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	seizures	NNS	8784	8792
1526	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	were	VBD	8793	8797
1527	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	related	VBN	8798	8805
1528	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	to	TO	8806	8808
1529	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	the	DT	8809	8812
1530	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	cyst	NN	8813	8817
1531	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	collapse	NN	8818	8826
1532	PMC6712354.nxml.gz	PMC6712354.nxml.gz_60	8559	8827	.	.	8826	8827
1533	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	He	PRP	8828	8830
1534	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	underwent	VBD	8831	8840
1535	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	a	DT	8841	8842
1536	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	complete	JJ	8843	8851
1537	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	workup	NN	8852	8858
1538	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	for	IN	8859	8862
1539	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	evaluation	NN	8863	8873
1540	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	of	IN	8874	8876
1541	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	his	PRP$	8877	8880
1542	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	seizures	NNS	8881	8889
1543	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	and	CC	8890	8893
1544	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	was	VBD	8894	8897
1545	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	found	VBN	8898	8903
1546	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	to	TO	8904	8906
1547	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	have	VB	8907	8911
1548	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	normal	JJ	8912	8918
1549	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	metabolic	JJ	8919	8928
1550	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	labs	NN	8929	8933
1551	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	,	,	8933	8934
1552	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	no	DT	8935	8937
1553	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	evidence	NN	8938	8946
1554	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	of	IN	8947	8949
1555	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	vascular	JJ	8950	8958
1556	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	changes	NNS	8959	8966
1557	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	,	,	8966	8967
1558	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	and	CC	8968	8971
1559	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	no	DT	8972	8974
1560	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	residual	JJ	8975	8983
1561	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	edema	NN	8984	8989
1562	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	from	IN	8990	8994
1563	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	his	PRP$	8995	8998
1564	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	previous	JJ	8999	9007
1565	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	bleomycin	NN	9008	9017
1566	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	treatment	NN	9018	9027
1567	PMC6712354.nxml.gz	PMC6712354.nxml.gz_61	8828	9028	.	.	9027	9028
1568	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	EEG	NNP	9029	9032
1569	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	evidence	NN	9033	9041
1570	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	shows	NNS	9042	9047
1571	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	seizures	NNS	9048	9056
1572	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	arise	VBP	9057	9062
1573	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	in	IN	9063	9065
1574	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	the	DT	9066	9069
1575	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	right	JJ	9070	9075
1576	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	temporal	JJ	9076	9084
1577	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	region	NN	9085	9091
1578	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	which	WDT	9092	9097
1579	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	is	VBZ	9098	9100
1580	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	associated	VBN	9101	9111
1581	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	with	IN	9112	9116
1582	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	significant	JJ	9117	9128
1583	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	cystic	JJ	9129	9135
1584	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	disease	NN	9136	9143
1585	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	burden	NN	9144	9150
1586	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	and	CC	9151	9154
1587	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	felt	VBD	9155	9159
1588	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	to	TO	9160	9162
1589	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	be	VB	9163	9165
1590	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	the	DT	9166	9169
1591	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	underlying	JJ	9170	9180
1592	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	cause	NN	9181	9186
1593	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	of	IN	9187	9189
1594	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	his	PRP$	9190	9193
1595	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	seizures	NNS	9194	9202
1596	PMC6712354.nxml.gz	PMC6712354.nxml.gz_62	9029	9203	.	.	9202	9203
1597	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	His	PRP$	9204	9207
1598	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	seizures	NNS	9208	9216
1599	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	were	VBD	9217	9221
1600	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	controlled	VBN	9222	9232
1601	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	with	IN	9233	9237
1602	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	levetiracetam	NN	9238	9251
1603	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	and	CC	9252	9255
1604	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	he	PRP	9256	9258
1605	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	continued	VBD	9259	9268
1606	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	treatment	NN	9269	9278
1607	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	with	IN	9279	9283
1608	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	tocilizumab	NN	9284	9295
1609	PMC6712354.nxml.gz	PMC6712354.nxml.gz_63	9204	9296	.	.	9295	9296
1610	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	Following	VBG	9297	9306
1611	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	8	CD	9307	9308
1612	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	months	NNS	9309	9315
1613	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	of	IN	9316	9318
1614	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	therapy	NN	9319	9326
1615	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	,	,	9326	9327
1616	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	MRI	NNP	9328	9331
1617	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	showed	VBD	9332	9338
1618	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	evidence	NN	9339	9347
1619	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	of	IN	9348	9350
1620	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	progression	NN	9351	9362
1621	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	of	IN	9363	9365
1622	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	the	DT	9366	9369
1623	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	cystic	JJ	9370	9376
1624	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	component	NN	9377	9386
1625	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	of	IN	9387	9389
1626	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	his	PRP$	9390	9393
1627	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	ACP	NNP	9394	9397
1628	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	(	(	9398	9399
1629	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	Figure	NNP	9399	9405
1630	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	1	CD	9406	9407
1631	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	,	,	9407	9408
1632	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	graph	NN	9409	9414
1633	PMC6712354.nxml.gz	PMC6712354.nxml.gz_64	9297	9416	).	NN	9414	9416
1634	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	The	DT	9417	9420
1635	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	patient	NN	9421	9428
1636	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	experienced	VBD	9429	9440
1637	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	increased	JJ	9441	9450
1638	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	headaches	NNS	9451	9460
1639	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	and	CC	9461	9464
1640	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	required	VBN	9465	9473
1641	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	intensified	JJ	9474	9485
1642	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	supportive	JJ	9486	9496
1643	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	care	NN	9497	9501
1644	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	including	VBG	9502	9511
1645	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	narcotic	JJ	9512	9520
1646	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	pain	NN	9521	9525
1647	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	medication	NN	9526	9536
1648	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	to	TO	9537	9539
1649	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	support	VB	9540	9547
1650	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	his	PRP$	9548	9551
1651	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	pain	NN	9552	9556
1652	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	control	NN	9557	9564
1653	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	needs	VBZ	9565	9570
1654	PMC6712354.nxml.gz	PMC6712354.nxml.gz_65	9417	9571	.	.	9570	9571
1655	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	Treatment	NN	9572	9581
1656	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	options	NNS	9582	9589
1657	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	were	VBD	9590	9594
1658	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	discussed	VBN	9595	9604
1659	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	including	VBG	9605	9614
1660	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	surgery	NN	9615	9622
1661	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	and	CC	9623	9626
1662	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	radiation	NN	9627	9636
1663	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	,	,	9636	9637
1664	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	but	CC	9638	9641
1665	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	both	DT	9642	9646
1666	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	options	NNS	9647	9654
1667	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	were	VBD	9655	9659
1668	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	deemed	VBN	9660	9666
1669	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	to	TO	9667	9669
1670	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	have	VB	9670	9674
1671	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	significant	JJ	9675	9686
1672	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	morbidity	NN	9687	9696
1673	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	risks	NNS	9697	9702
1674	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	by	IN	9703	9705
1675	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	the	DT	9706	9709
1676	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	family	NN	9710	9716
1677	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	,	,	9716	9717
1678	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	and	CC	9718	9721
1679	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	they	PRP	9722	9726
1680	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	requested	VBD	9727	9736
1681	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	an	DT	9737	9739
1682	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	alternative	JJ	9740	9751
1683	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	chemotherapy	NN	9752	9764
1684	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	plan	NN	9765	9769
1685	PMC6712354.nxml.gz	PMC6712354.nxml.gz_66	9572	9770	.	.	9769	9770
1686	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	At	IN	9771	9773
1687	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	this	DT	9774	9778
1688	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	time	NN	9779	9783
1689	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	,	,	9783	9784
1690	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	an	DT	9785	9787
1691	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	attempt	NN	9788	9795
1692	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	to	TO	9796	9798
1693	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	treat	VB	9799	9804
1694	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	his	PRP$	9805	9808
1695	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	disease	NN	9809	9816
1696	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	with	IN	9817	9821
1697	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	combination	NN	9822	9833
1698	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	bevacizumab	NN	9834	9845
1699	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	and	CC	9846	9849
1700	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	tocilizumab	NN	9850	9861
1701	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	was	VBD	9862	9865
1702	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	initiated	VBN	9866	9875
1703	PMC6712354.nxml.gz	PMC6712354.nxml.gz_67	9771	9876	.	.	9875	9876
1704	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	Bevacizumab	NNP	9877	9888
1705	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	was	VBD	9889	9892
1706	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	added	VBN	9893	9898
1707	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	as	IN	9899	9901
1708	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	potential	JJ	9902	9911
1709	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	additional	JJ	9912	9922
1710	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	cyst	NN	9923	9927
1711	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	directed	VBD	9928	9936
1712	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	therapy	NN	9937	9944
1713	PMC6712354.nxml.gz	PMC6712354.nxml.gz_68	9877	9945	.	.	9944	9945
1714	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	Systemic	NNP	9947	9955
1715	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	IV	NNP	9956	9958
1716	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	tocilizumab	NN	9959	9970
1717	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	in	IN	9971	9973
1718	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	combination	NN	9974	9985
1719	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	with	IN	9986	9990
1720	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	IV	NNP	9991	9993
1721	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	bevacizumab	NN	9994	10005
1722	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	every	DT	10006	10011
1723	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	2	CD	10012	10013
1724	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	weeks	NNS	10014	10019
1725	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	was	VBD	10020	10023
1726	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	generally	RB	10024	10033
1727	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	well	RB	10034	10038
1728	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	tolerated	VBN	10039	10048
1729	PMC6712354.nxml.gz	PMC6712354.nxml.gz_69	9947	10049	.	.	10048	10049
1730	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	There	EX	10050	10055
1731	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	were	VBD	10056	10060
1732	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	three	CD	10061	10066
1733	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	delays	NNS	10067	10073
1734	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	in	IN	10074	10076
1735	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	therapy	NN	10077	10084
1736	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	of	IN	10085	10087
1737	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	2	CD	10088	10089
1738	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	weeks	NNS	10090	10095
1739	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	for	IN	10096	10099
1740	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	the	DT	10100	10103
1741	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	first	JJ	10104	10109
1742	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	two	CD	10110	10113
1743	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	delays	NNS	10114	10120
1744	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	and	CC	10121	10124
1745	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	4	CD	10125	10126
1746	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	weeks	NNS	10127	10132
1747	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	for	IN	10133	10136
1748	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	the	DT	10137	10140
1749	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	third	JJ	10141	10146
1750	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	delay	NN	10147	10152
1751	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	due	JJ	10153	10156
1752	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	to	TO	10157	10159
1753	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	neutropenia	VB	10160	10171
1754	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	(	(	10172	10173
1755	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	CTCAE	NNP	10173	10178
1756	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	v5	NN	10179	10181
1757	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	,	,	10181	10182
1758	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	Grade	NNP	10183	10188
1759	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	3	CD	10189	10190
1760	PMC6712354.nxml.gz	PMC6712354.nxml.gz_70	10050	10192	).	NN	10190	10192
1761	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	There	EX	10193	10198
1762	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	were	VBD	10199	10203
1763	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	no	DT	10204	10206
1764	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	fevers	NNS	10207	10213
1765	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	or	CC	10214	10216
1766	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	signs	NNS	10217	10222
1767	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	of	IN	10223	10225
1768	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	systemic	JJ	10226	10234
1769	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	illness	NN	10235	10242
1770	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	associated	VBN	10243	10253
1771	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	with	IN	10254	10258
1772	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	these	DT	10259	10264
1773	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	episodes	NNS	10265	10273
1774	PMC6712354.nxml.gz	PMC6712354.nxml.gz_71	10193	10274	.	.	10273	10274
1775	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	In	IN	10275	10277
1776	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	total	JJ	10278	10283
1777	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	,	,	10283	10284
1778	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	he	PRP	10285	10287
1779	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	received	VBD	10288	10296
1780	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	14	CD	10297	10299
1781	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	months	NNS	10300	10306
1782	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	of	IN	10307	10309
1783	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	combination	NN	10310	10321
1784	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	therapy	NN	10322	10329
1785	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	over	IN	10330	10334
1786	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	28	CD	10335	10337
1787	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	months	NNS	10338	10344
1788	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	with	IN	10345	10349
1789	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	MRIs	NNP	10350	10354
1790	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	showing	VBG	10355	10362
1791	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	a	DT	10363	10364
1792	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	significant	JJ	10365	10376
1793	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	decrease	NN	10377	10385
1794	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	in	IN	10386	10388
1795	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	cystic	JJ	10389	10395
1796	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	disease	NN	10396	10403
1797	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	(	(	10404	10405
1798	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	Figure	NNP	10405	10411
1799	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	1E	CD	10412	10414
1800	PMC6712354.nxml.gz	PMC6712354.nxml.gz_72	10275	10416	).	NN	10414	10416
1801	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	Following	VBG	10417	10426
1802	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	multiple	JJ	10427	10435
1803	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	scans	NNS	10436	10441
1804	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	with	IN	10442	10446
1805	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	stable	JJ	10447	10453
1806	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	disease	NN	10454	10461
1807	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	,	,	10461	10462
1808	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	the	DT	10463	10466
1809	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	primary	JJ	10467	10474
1810	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	oncologist	NN	10475	10485
1811	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	and	CC	10486	10489
1812	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	family	NN	10490	10496
1813	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	elected	VBN	10497	10504
1814	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	for	IN	10505	10508
1815	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	a	DT	10509	10510
1816	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	therapy	NN	10511	10518
1817	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	break	NN	10519	10524
1818	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	with	IN	10525	10529
1819	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	routine	JJ	10530	10537
1820	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	tumor	NN	10538	10543
1821	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	surveillance	NN	10544	10556
1822	PMC6712354.nxml.gz	PMC6712354.nxml.gz_73	10417	10557	.	.	10556	10557
1823	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	Three	CD	10559	10564
1824	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	months	NNS	10565	10571
1825	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	off	IN	10572	10575
1826	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	of	IN	10576	10578
1827	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	therapy	NN	10579	10586
1828	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	,	,	10586	10587
1829	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	an	DT	10588	10590
1830	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	MRI	NNP	10591	10594
1831	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	showed	VBD	10595	10601
1832	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	a	DT	10602	10603
1833	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	minimal	JJ	10604	10611
1834	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	increase	NN	10612	10620
1835	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	in	IN	10621	10623
1836	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	some	DT	10624	10628
1837	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	cystic	JJ	10629	10635
1838	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	components	NNS	10636	10646
1839	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	while	IN	10647	10652
1840	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	the	DT	10653	10656
1841	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	remainder	NN	10657	10666
1842	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	of	IN	10667	10669
1843	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	the	DT	10670	10673
1844	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	solid	JJ	10674	10679
1845	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	and	CC	10680	10683
1846	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	cystic	JJ	10684	10690
1847	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	components	NNS	10691	10701
1848	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	remained	VBD	10702	10710
1849	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	unchanged	JJ	10711	10720
1850	PMC6712354.nxml.gz	PMC6712354.nxml.gz_74	10559	10721	.	.	10720	10721
1851	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	Six	CD	10722	10725
1852	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	months	NNS	10726	10732
1853	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	off	IN	10733	10736
1854	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	therapy	NN	10737	10744
1855	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	the	DT	10745	10748
1856	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	patient	NN	10749	10756
1857	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	was	VBD	10757	10760
1858	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	seen	VBN	10761	10765
1859	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	in	IN	10766	10768
1860	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	the	DT	10769	10772
1861	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	Emergency	NNP	10773	10782
1862	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	Department	NNP	10783	10793
1863	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	with	IN	10794	10798
1864	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	seizure	NN	10799	10806
1865	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	activity	NN	10807	10815
1866	PMC6712354.nxml.gz	PMC6712354.nxml.gz_75	10722	10816	.	.	10815	10816
1867	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	At	IN	10817	10819
1868	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	this	DT	10820	10824
1869	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	time	NN	10825	10829
1870	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	,	,	10829	10830
1871	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	an	DT	10831	10833
1872	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	MRI	NNP	10834	10837
1873	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	demonstrated	VBD	10838	10850
1874	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	an	DT	10851	10853
1875	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	overall	JJ	10854	10861
1876	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	increase	NN	10862	10870
1877	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	in	IN	10871	10873
1878	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	his	PRP$	10874	10877
1879	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	cystic	JJ	10878	10884
1880	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	mass	NN	10885	10889
1881	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	(	(	10890	10891
1882	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	Figure	NNP	10891	10897
1883	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	1F	CD	10898	10900
1884	PMC6712354.nxml.gz	PMC6712354.nxml.gz_76	10817	10902	).	NN	10900	10902
1885	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	Bevacizumab	NNP	10903	10914
1886	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	and	CC	10915	10918
1887	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	tocilizumab	NN	10919	10930
1888	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	were	VBD	10931	10935
1889	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	re	JJ	10936	10938
1890	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	-	:	10938	10939
1891	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	initiated	VBN	10939	10948
1892	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	with	IN	10949	10953
1893	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	a	DT	10954	10955
1894	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	significant	JJ	10956	10967
1895	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	decrease	NN	10968	10976
1896	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	in	IN	10977	10979
1897	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	cystic	JJ	10980	10986
1898	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	disease	NN	10987	10994
1899	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	following	VBG	10995	11004
1900	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	4	CD	11005	11006
1901	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	months	NNS	11007	11013
1902	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	of	IN	11014	11016
1903	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	therapy	NN	11017	11024
1904	PMC6712354.nxml.gz	PMC6712354.nxml.gz_77	10903	11025	.	.	11024	11025
1905	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	The	DT	11026	11029
1906	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	patient	NN	11030	11037
1907	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	has	VBZ	11038	11041
1908	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	remained	VBN	11042	11050
1909	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	on	IN	11051	11053
1910	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	combination	NN	11054	11065
1911	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	therapy	NN	11066	11073
1912	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	for	IN	11074	11077
1913	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	13	CD	11078	11080
1914	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	months	NNS	11081	11087
1915	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	(	(	11088	11089
1916	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	Figure	NNP	11089	11095
1917	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	1G	CD	11096	11098
1918	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	),	NN	11098	11100
1919	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	to	TO	11101	11103
1920	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	date	NN	11104	11108
1921	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	,	,	11108	11109
1922	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	and	CC	11110	11113
1923	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	his	PRP$	11114	11117
1924	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	seizures	NNS	11118	11126
1925	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	are	VBP	11127	11130
1926	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	controlled	VBN	11131	11141
1927	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	with	IN	11142	11146
1928	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	levetiracetam	NN	11147	11160
1929	PMC6712354.nxml.gz	PMC6712354.nxml.gz_78	11026	11161	.	.	11160	11161
1930	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	Case	NNP	11163	11167
1931	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	2	CD	11168	11169
1932	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	Presentation	NNP	11170	11182
1933	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	A	NNP	11184	11185
1934	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	7	CD	11186	11187
1935	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	-	:	11187	11188
1936	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	year	NN	11188	11192
1937	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	-	:	11192	11193
1938	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	old	JJ	11193	11196
1939	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	male	NN	11197	11201
1940	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	presented	VBN	11202	11211
1941	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	with	IN	11212	11216
1942	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	a	DT	11217	11218
1943	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	1	CD	11219	11220
1944	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	month	NN	11221	11226
1945	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	-	:	11226	11227
1946	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	long	JJ	11227	11231
1947	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	history	NN	11232	11239
1948	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	of	IN	11240	11242
1949	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	nausea	NN	11243	11249
1950	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	and	CC	11250	11253
1951	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	vomiting	NN	11254	11262
1952	PMC6712354.nxml.gz	PMC6712354.nxml.gz_79	11163	11263	.	.	11262	11263
1953	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	A	DT	11264	11265
1954	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	head	NN	11266	11270
1955	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	CT	NNP	11271	11273
1956	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	was	VBD	11274	11277
1957	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	performed	VBN	11278	11287
1958	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	for	IN	11288	11291
1959	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	concern	NN	11292	11299
1960	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	for	IN	11300	11303
1961	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	increased	VBN	11304	11313
1962	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	intracranial	JJ	11314	11326
1963	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	pressure	NN	11327	11335
1964	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	and	CC	11336	11339
1965	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	demonstrated	VBD	11340	11352
1966	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	a	DT	11353	11354
1967	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	large	JJ	11355	11360
1968	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	cystic	JJ	11361	11367
1969	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	frontal	JJ	11368	11375
1970	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	mass	NN	11376	11380
1971	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	that	WDT	11381	11385
1972	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	crossed	VBD	11386	11393
1973	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	the	DT	11394	11397
1974	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	midline	NN	11398	11405
1975	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	,	,	11405	11406
1976	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	with	IN	11407	11411
1977	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	perilesional	JJ	11412	11424
1978	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	edema	NN	11425	11430
1979	PMC6712354.nxml.gz	PMC6712354.nxml.gz_80	11264	11431	.	.	11430	11431
1980	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	His	PRP$	11432	11435
1981	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	past	JJ	11436	11440
1982	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	medical	JJ	11441	11448
1983	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	history	NN	11449	11456
1984	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	was	VBD	11457	11460
1985	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	significant	JJ	11461	11472
1986	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	for	IN	11473	11476
1987	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	a	DT	11477	11478
1988	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	diagnosis	NN	11479	11488
1989	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	of	IN	11489	11491
1990	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	â	NNP	11492	11493
1991	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601		NNP	11493	11495
1992	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	lazy	JJ	11495	11499
1993	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	eyeâ	NN	11500	11504
1994	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601		NN	11504	11506
1995	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	1	CD	11507	11508
1996	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	year	NN	11509	11513
1997	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	previously	RB	11514	11524
1998	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	and	CC	11525	11528
1999	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	short	JJ	11529	11534
2000	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	stature	NN	11535	11542
2001	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	(	(	11543	11544
2002	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	later	RB	11544	11549
2003	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	determined	VBN	11550	11560
2004	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	to	TO	11561	11563
2005	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	be	VB	11564	11566
2006	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	due	JJ	11567	11570
2007	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	to	TO	11571	11573
2008	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	growth	NN	11574	11580
2009	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	hormone	NN	11581	11588
2010	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	deficiency	NN	11589	11599
2011	PMC6712354.nxml.gz	PMC6712354.nxml.gz_81	11432	11601	).	NN	11599	11601
2012	PMC6712354.nxml.gz	PMC6712354.nxml.gz_82	11602	11634	Family	RB	11602	11608
2013	PMC6712354.nxml.gz	PMC6712354.nxml.gz_82	11602	11634	history	NN	11609	11616
2014	PMC6712354.nxml.gz	PMC6712354.nxml.gz_82	11602	11634	was	VBD	11617	11620
2015	PMC6712354.nxml.gz	PMC6712354.nxml.gz_82	11602	11634	unremarkable	JJ	11621	11633
2016	PMC6712354.nxml.gz	PMC6712354.nxml.gz_82	11602	11634	.	.	11633	11634
2017	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	MRI	NNP	11636	11639
2018	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	brain	NN	11640	11645
2019	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	demonstrated	VBD	11646	11658
2020	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	a	DT	11659	11660
2021	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	large	JJ	11661	11666
2022	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	cystic	JJ	11667	11673
2023	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	sellar	NN	11674	11680
2024	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	/	NNP	11680	11681
2025	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	suprasellar	JJ	11681	11692
2026	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	mass	NN	11693	11697
2027	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	,	,	11697	11698
2028	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	most	RBS	11699	11703
2029	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	consistent	JJ	11704	11714
2030	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	with	IN	11715	11719
2031	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	craniopharyngioma	NN	11720	11737
2032	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	(	(	11738	11739
2033	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	Figure	NNP	11739	11745
2034	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	2A	CD	11746	11748
2035	PMC6712354.nxml.gz	PMC6712354.nxml.gz_83	11636	11750	).	NN	11748	11750
2036	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	MRI	NNP	11751	11754
2037	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	volume	NN	11755	11761
2038	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	measures	NNS	11762	11770
2039	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	as	IN	11771	11773
2040	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	with	IN	11774	11778
2041	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	Case	NNP	11779	11783
2042	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	1	CD	11784	11785
2043	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	demonstrated	VBD	11786	11798
2044	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	primary	JJ	11799	11806
2045	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	cystic	JJ	11807	11813
2046	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	disease	NN	11814	11821
2047	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	with	IN	11822	11826
2048	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	minimal	JJ	11827	11834
2049	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	solid	JJ	11835	11840
2050	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	tumor	NN	11841	11846
2051	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	component	NN	11847	11856
2052	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	(	(	11857	11858
2053	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	Figure	NNP	11858	11864
2054	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	2	CD	11865	11866
2055	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	,	,	11866	11867
2056	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	graph	NN	11868	11873
2057	PMC6712354.nxml.gz	PMC6712354.nxml.gz_84	11751	11875	).	NN	11873	11875
2058	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	Initial	JJ	11876	11883
2059	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	surgical	JJ	11884	11892
2060	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	management	NN	11893	11903
2061	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	included	VBD	11904	11912
2062	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	stereotactic	JJ	11913	11925
2063	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	cyst	NN	11926	11930
2064	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	catheter	NN	11931	11939
2065	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	placement	NN	11940	11949
2066	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	with	IN	11950	11954
2067	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	concomitant	JJ	11955	11966
2068	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	drainage	NN	11967	11975
2069	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	of	IN	11976	11978
2070	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	~	$	11979	11980
2071	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	50	CD	11980	11982
2072	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	mL	NN	11983	11985
2073	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	of	IN	11986	11988
2074	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	â	JJ	11989	11990
2075	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023		FW	11990	11992
2076	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	machine	NN	11992	11999
2077	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	oilâ	IN	12000	12004
2078	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	-	JJ	12004	12007
2079	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	like	IN	12007	12011
2080	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	cyst	NN	12012	12016
2081	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	fluid	NN	12017	12022
2082	PMC6712354.nxml.gz	PMC6712354.nxml.gz_85	11876	12023	.	.	12022	12023
2083	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	His	PRP$	12024	12027
2084	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	initial	JJ	12028	12035
2085	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	post	NN	12036	12040
2086	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	-	:	12040	12041
2087	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	operative	JJ	12041	12050
2088	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	course	NN	12051	12057
2089	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	was	VBD	12058	12061
2090	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	uneventful	JJ	12062	12072
2091	PMC6712354.nxml.gz	PMC6712354.nxml.gz_86	12024	12073	.	.	12072	12073
2092	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	Caption	NNP	12075	12082
2093	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	(	(	12083	12084
2094	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	Fig	NNP	12084	12087
2095	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	):	NNP	12087	12089
2096	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	FIG	NNP	12090	12093
2097	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	2	CD	12094	12095
2098	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	Cyst	NNP	12097	12101
2099	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	volume	NN	12102	12108
2100	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	(	(	12109	12110
2101	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	cm3	NN	12110	12113
2102	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	)	)	12113	12114
2103	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	in	IN	12115	12117
2104	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	response	NN	12118	12126
2105	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	to	TO	12127	12129
2106	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	treatment	NN	12130	12139
2107	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	course	NN	12140	12146
2108	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	for	IN	12147	12150
2109	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	patient	JJ	12151	12158
2110	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	2	CD	12159	12160
2111	PMC6712354.nxml.gz	PMC6712354.nxml.gz_87	12075	12161	.	.	12160	12161
2112	PMC6712354.nxml.gz	PMC6712354.nxml.gz_88	12162	12182	(	(	12162	12163
2113	PMC6712354.nxml.gz	PMC6712354.nxml.gz_88	12162	12182	A	DT	12163	12164
2114	PMC6712354.nxml.gz	PMC6712354.nxml.gz_88	12162	12182	)	)	12164	12165
2115	PMC6712354.nxml.gz	PMC6712354.nxml.gz_88	12162	12182	Diagnostic	NNP	12166	12176
2116	PMC6712354.nxml.gz	PMC6712354.nxml.gz_88	12162	12182	MRis	NNP	12177	12181
2117	PMC6712354.nxml.gz	PMC6712354.nxml.gz_88	12162	12182	.	.	12181	12182
2118	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	(	(	12183	12184
2119	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	B	NNP	12184	12185
2120	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	)	)	12185	12186
2121	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	Scan	NNP	12187	12191
2122	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	immediately	RB	12192	12203
2123	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	before	IN	12204	12210
2124	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	ommaya	JJ	12211	12217
2125	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	reservoir	NN	12218	12227
2126	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	replacement	NN	12228	12239
2127	PMC6712354.nxml.gz	PMC6712354.nxml.gz_89	12183	12240	.	.	12239	12240
2128	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	(	(	12241	12242
2129	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	C	NNP	12242	12243
2130	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	)	)	12243	12244
2131	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	Scan	NNP	12245	12249
2132	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	immediately	RB	12250	12261
2133	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	stopping	VBG	12262	12270
2134	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	bleomycin	NN	12271	12280
2135	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	for	IN	12281	12284
2136	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	right	JJ	12285	12290
2137	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	frontal	JJ	12291	12298
2138	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	lobe	NN	12299	12303
2139	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	edema	NN	12304	12309
2140	PMC6712354.nxml.gz	PMC6712354.nxml.gz_90	12241	12310	.	.	12309	12310
2141	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	(	(	12311	12312
2142	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	D	NNP	12312	12313
2143	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	)	)	12313	12314
2144	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	Scan	NNP	12315	12319
2145	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	while	IN	12320	12325
2146	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	on	IN	12326	12328
2147	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	Tocilizumab	NNP	12329	12340
2148	PMC6712354.nxml.gz	PMC6712354.nxml.gz_91	12311	12341	.	.	12340	12341
2149	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	(	(	12342	12343
2150	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	E	NN	12343	12344
2151	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	)	)	12344	12345
2152	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	Patient	VBD	12346	12353
2153	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	two	CD	12354	12357
2154	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	cyst	NN	12358	12362
2155	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	volume	NN	12363	12369
2156	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	(	(	12370	12371
2157	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	cm3	NN	12371	12374
2158	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	)	)	12374	12375
2159	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	in	IN	12376	12378
2160	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	response	NN	12379	12387
2161	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	to	TO	12388	12390
2162	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	treatment	NN	12391	12400
2163	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	course	NN	12401	12407
2164	PMC6712354.nxml.gz	PMC6712354.nxml.gz_92	12342	12408	.	.	12407	12408
2165	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	The	DT	12410	12413
2166	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	patient	NN	12414	12421
2167	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	returned	VBD	12422	12430
2168	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	to	TO	12431	12433
2169	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	the	DT	12434	12437
2170	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	outpatient	NN	12438	12448
2171	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	clinic	NN	12449	12455
2172	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	for	IN	12456	12459
2173	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	weekly	JJ	12460	12466
2174	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	cyst	NN	12467	12471
2175	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	aspiration	NN	12472	12482
2176	PMC6712354.nxml.gz	PMC6712354.nxml.gz_93	12410	12483	.	.	12482	12483
2177	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	Three	CD	12484	12489
2178	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	months	NNS	12490	12496
2179	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	after	IN	12497	12502
2180	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	catheter	NN	12503	12511
2181	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	placement	NN	12512	12521
2182	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	,	,	12521	12522
2183	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	MRI	NNP	12523	12526
2184	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	demonstrated	VBD	12527	12539
2185	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	an	DT	12540	12542
2186	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	increase	NN	12543	12551
2187	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	in	IN	12552	12554
2188	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	cyst	NN	12555	12559
2189	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	size	NN	12560	12564
2190	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	(	(	12565	12566
2191	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	Figure	NNP	12566	12572
2192	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	2B	CD	12573	12575
2193	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	),	NN	12575	12577
2194	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	and	CC	12578	12581
2195	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	repositioning	NN	12582	12595
2196	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	of	IN	12596	12598
2197	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	the	DT	12599	12602
2198	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	catheter	NN	12603	12611
2199	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	was	VBD	12612	12615
2200	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	undertaken	VBN	12616	12626
2201	PMC6712354.nxml.gz	PMC6712354.nxml.gz_94	12484	12627	.	.	12626	12627
2202	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	Resumption	NN	12628	12638
2203	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	of	IN	12639	12641
2204	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	scheduled	JJ	12642	12651
2205	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	cyst	NN	12652	12656
2206	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	aspiration	NN	12657	12667
2207	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	again	RB	12668	12673
2208	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	led	VBD	12674	12677
2209	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	to	TO	12678	12680
2210	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	a	DT	12681	12682
2211	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	decrease	NN	12683	12691
2212	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	in	IN	12692	12694
2213	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	the	DT	12695	12698
2214	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	cyst	NN	12699	12703
2215	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	size	NN	12704	12708
2216	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	(	(	12709	12710
2217	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	Figure	NNP	12710	12716
2218	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	2	CD	12717	12718
2219	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	,	,	12718	12719
2220	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	graph	NN	12720	12725
2221	PMC6712354.nxml.gz	PMC6712354.nxml.gz_95	12628	12727	).	NN	12725	12727
2222	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	However	RB	12728	12735
2223	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	,	,	12735	12736
2224	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	due	JJ	12737	12740
2225	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	to	TO	12741	12743
2226	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	the	DT	12744	12747
2227	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	need	NN	12748	12752
2228	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	for	IN	12753	12756
2229	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	continued	JJ	12757	12766
2230	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	cyst	NN	12767	12771
2231	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	aspiration	NN	12772	12782
2232	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	,	,	12782	12783
2233	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	and	CC	12784	12787
2234	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	the	DT	12788	12791
2235	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	position	NN	12792	12800
2236	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	of	IN	12801	12803
2237	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	the	DT	12804	12807
2238	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	tumor	NN	12808	12813
2239	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	,	,	12813	12814
2240	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	which	WDT	12815	12820
2241	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	appeared	VBD	12821	12829
2242	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	amenable	JJ	12830	12838
2243	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	to	TO	12839	12841
2244	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	gross	JJ	12842	12847
2245	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	surgical	JJ	12848	12856
2246	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	excision	NN	12857	12865
2247	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	,	,	12865	12866
2248	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	craniotomy	NN	12867	12877
2249	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	for	IN	12878	12881
2250	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	tumor	NN	12882	12887
2251	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	removal	NN	12888	12895
2252	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	was	VBD	12896	12899
2253	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	undertaken	VBN	12900	12910
2254	PMC6712354.nxml.gz	PMC6712354.nxml.gz_96	12728	12911	.	.	12910	12911
2255	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	At	IN	12912	12914
2256	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	surgery	NN	12915	12922
2257	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	,	,	12922	12923
2258	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	the	DT	12924	12927
2259	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	cyst	NN	12928	12932
2260	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	wall	NN	12933	12937
2261	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	was	VBD	12938	12941
2262	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	densely	RB	12942	12949
2263	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	adherent	JJ	12950	12958
2264	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	to	TO	12959	12961
2265	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	the	DT	12962	12965
2266	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	anterior	JJ	12966	12974
2267	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	cerebral	JJ	12975	12983
2268	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	vessels	NNS	12984	12991
2269	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	,	,	12991	12992
2270	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	and	CC	12993	12996
2271	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	subtotal	JJ	12997	13005
2272	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	resection	NN	13006	13015
2273	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	was	VBD	13016	13019
2274	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	achieved	VBN	13020	13028
2275	PMC6712354.nxml.gz	PMC6712354.nxml.gz_97	12912	13029	.	.	13028	13029
2276	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	The	DT	13030	13033
2277	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	patient	NN	13034	13041
2278	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	was	VBD	13042	13045
2279	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	treated	VBN	13046	13053
2280	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	with	IN	13054	13058
2281	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	focal	JJ	13059	13064
2282	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	radiation	NN	13065	13074
2283	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	(	(	13075	13076
2284	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	54	CD	13076	13078
2285	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	Gy	NNP	13079	13081
2286	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	in	IN	13082	13084
2287	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	30	CD	13085	13087
2288	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	fractions	NNS	13088	13097
2289	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	)	)	13097	13098
2290	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	but	CC	13099	13102
2291	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	was	VBD	13103	13106
2292	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	noted	VBN	13107	13112
2293	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	to	TO	13113	13115
2294	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	have	VB	13116	13120
2295	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	rapid	JJ	13121	13126
2296	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	cyst	NN	13127	13131
2297	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	recurrence	NN	13132	13142
2298	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	during	IN	13143	13149
2299	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	radiation	NN	13150	13159
2300	PMC6712354.nxml.gz	PMC6712354.nxml.gz_98	13030	13160	.	.	13159	13160
2301	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	Following	VBG	13161	13170
2302	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	completion	NN	13171	13181
2303	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	of	IN	13182	13184
2304	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	radiation	NN	13185	13194
2305	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	,	,	13194	13195
2306	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	a	DT	13196	13197
2307	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	cyst	NN	13198	13202
2308	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	catheter	NN	13203	13211
2309	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	was	VBD	13212	13215
2310	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	replaced	VBN	13216	13224
2311	PMC6712354.nxml.gz	PMC6712354.nxml.gz_99	13161	13225	.	.	13224	13225
2312	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	The	DT	13226	13229
2313	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	patient	NN	13230	13237
2314	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	was	VBD	13238	13241
2315	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	treated	VBN	13242	13249
2316	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	with	IN	13250	13254
2317	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	intracystic	JJ	13255	13266
2318	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	bleomycin	NN	13267	13276
2319	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	,	,	13276	13277
2320	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	which	WDT	13278	13283
2321	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	resulted	VBD	13284	13292
2322	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	in	IN	13293	13295
2323	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	an	DT	13296	13298
2324	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	initial	JJ	13299	13306
2325	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	decrease	NN	13307	13315
2326	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	in	IN	13316	13318
2327	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	cyst	NN	13319	13323
2328	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	size	NN	13324	13328
2329	PMC6712354.nxml.gz	PMC6712354.nxml.gz_100	13226	13329	.	.	13328	13329
2330	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	However	RB	13330	13337
2331	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	,	,	13337	13338
2332	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	after	IN	13339	13344
2333	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	1	CD	13345	13346
2334	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	month	NN	13347	13352
2335	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	,	,	13352	13353
2336	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	the	DT	13354	13357
2337	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	patient	NN	13358	13365
2338	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	developed	VBD	13366	13375
2339	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	new	JJ	13376	13379
2340	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	onset	NN	13380	13385
2341	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	lethargy	NN	13386	13394
2342	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	,	,	13394	13395
2343	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	and	CC	13396	13399
2344	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	imaging	VBG	13400	13407
2345	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	demonstrated	VBN	13408	13420
2346	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	right	JJ	13421	13426
2347	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	frontal	NN	13427	13434
2348	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	lobe	NN	13435	13439
2349	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	edema	NN	13440	13445
2350	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	adjacent	NN	13446	13454
2351	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	to	TO	13455	13457
2352	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	the	DT	13458	13461
2353	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	cyst	NN	13462	13466
2354	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	wall	NN	13467	13471
2355	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	(	(	13472	13473
2356	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	Figure	NNP	13473	13479
2357	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	2C	CD	13480	13482
2358	PMC6712354.nxml.gz	PMC6712354.nxml.gz_101	13330	13484	).	NN	13482	13484
2359	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	He	PRP	13485	13487
2360	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	was	VBD	13488	13491
2361	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	treated	VBN	13492	13499
2362	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	with	IN	13500	13504
2363	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	dexamethasone	NN	13505	13518
2364	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	and	CC	13519	13522
2365	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	cessation	NN	13523	13532
2366	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	of	IN	13533	13535
2367	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	bleomycin	NN	13536	13545
2368	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	with	IN	13546	13550
2369	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	resolution	NN	13551	13561
2370	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	of	IN	13562	13564
2371	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	his	PRP$	13565	13568
2372	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	symptoms	NNS	13569	13577
2373	PMC6712354.nxml.gz	PMC6712354.nxml.gz_102	13485	13578	.	.	13577	13578
2374	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	The	DT	13580	13583
2375	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	patient	NN	13584	13591
2376	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	was	VBD	13592	13595
2377	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	offered	VBN	13596	13603
2378	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	systemic	JJ	13604	13612
2379	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	tocilizumab	NN	13613	13624
2380	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	(	(	13625	13626
2381	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	12	CD	13626	13628
2382	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	mg	NN	13629	13631
2383	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	/	NNP	13631	13632
2384	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	kg	NNP	13632	13634
2385	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	IV	NNP	13635	13637
2386	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	q2	NNP	13638	13640
2387	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	weeks	NNS	13641	13646
2388	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	)	)	13646	13647
2389	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	on	IN	13648	13650
2390	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	a	DT	13651	13652
2391	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	compassionate	NN	13653	13666
2392	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	use	NN	13667	13670
2393	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	basis	NN	13671	13676
2394	PMC6712354.nxml.gz	PMC6712354.nxml.gz_103	13580	13677	.	.	13676	13677
2395	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	After	IN	13678	13683
2396	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	6	CD	13684	13685
2397	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	months	NNS	13686	13692
2398	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	of	IN	13693	13695
2399	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	therapy	NN	13696	13703
2400	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	,	,	13703	13704
2401	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	the	DT	13705	13708
2402	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	cyst	NN	13709	13713
2403	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	exhibited	VBD	13714	13723
2404	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	a	DT	13724	13725
2405	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	partial	JJ	13726	13733
2406	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	response	NN	13734	13742
2407	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	with	IN	13743	13747
2408	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	measurements	NNS	13748	13760
2409	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	improved	VBN	13761	13769
2410	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	from	IN	13770	13774
2411	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	26	CD	13775	13777
2412	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNS	13778	13779
2413	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		VBD	13779	13780
2414	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	28	CD	13781	13783
2415	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNP	13784	13785
2416	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		VBD	13785	13786
2417	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	27	CD	13787	13789
2418	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	mm	NN	13790	13792
2419	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	(	(	13793	13794
2420	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	AP	NNP	13794	13796
2421	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNP	13797	13798
2422	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		NNP	13798	13799
2423	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	TRV	NNP	13800	13803
2424	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNP	13804	13805
2425	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		NNP	13805	13806
2426	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	CC	NNP	13807	13809
2427	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	)	)	13809	13810
2428	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	to	TO	13811	13813
2429	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	18	CD	13814	13816
2430	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNS	13817	13818
2431	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		VBD	13818	13819
2432	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	24	CD	13820	13822
2433	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNP	13823	13824
2434	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		VBD	13824	13825
2435	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	18	CD	13826	13828
2436	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	mm	NN	13829	13831
2437	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	(	(	13832	13833
2438	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	AP	NNP	13833	13835
2439	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNP	13836	13837
2440	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		NNP	13837	13838
2441	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	TRV	NNP	13839	13842
2442	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Ã	NNP	13843	13844
2443	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862		NNP	13844	13845
2444	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	CC	NNP	13846	13848
2445	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	)	)	13848	13849
2446	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	(	(	13850	13851
2447	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	Figure	$	13851	13857
2448	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	2D	CD	13858	13860
2449	PMC6712354.nxml.gz	PMC6712354.nxml.gz_104	13678	13862	).	NN	13860	13862
2450	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	He	PRP	13863	13865
2451	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	has	VBZ	13866	13869
2452	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	had	VBN	13870	13873
2453	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	no	DT	13874	13876
2454	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	significant	JJ	13877	13888
2455	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	adverse	JJ	13889	13896
2456	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	effects	NNS	13897	13904
2457	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	,	,	13904	13905
2458	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	no	DT	13906	13908
2459	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	new	JJ	13909	13912
2460	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	neurologic	JJ	13913	13923
2461	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	sequela	NN	13924	13931
2462	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	and	CC	13932	13935
2463	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	no	DT	13936	13938
2464	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	hospitalizations	NNS	13939	13955
2465	PMC6712354.nxml.gz	PMC6712354.nxml.gz_105	13863	13956	.	.	13955	13956
2466	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	Therapy	NN	13957	13964
2467	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	was	VBD	13965	13968
2468	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	discontinued	VBN	13969	13981
2469	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	after	IN	13982	13987
2470	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	seven	CD	13988	13993
2471	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	months	NNS	13994	14000
2472	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	,	,	14000	14001
2473	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	and	CC	14002	14005
2474	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	he	PRP	14006	14008
2475	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	continues	VBZ	14009	14018
2476	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	on	IN	14019	14021
2477	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	an	DT	14022	14024
2478	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	MRI	NNP	14025	14028
2479	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	monitoring	NN	14029	14039
2480	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	plan	NN	14040	14044
2481	PMC6712354.nxml.gz	PMC6712354.nxml.gz_106	13957	14045	.	.	14044	14045
2482	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	Discussion	NN	14047	14057
2483	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	Here	RB	14059	14063
2484	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	we	PRP	14064	14066
2485	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	report	VBP	14067	14073
2486	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	the	DT	14074	14077
2487	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	first	JJ	14078	14083
2488	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	use	NN	14084	14087
2489	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	of	IN	14088	14090
2490	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	tocilizumab	NN	14091	14102
2491	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	alone	RB	14103	14108
2492	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	or	CC	14109	14111
2493	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	in	IN	14112	14114
2494	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	combination	NN	14115	14126
2495	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	with	IN	14127	14131
2496	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	bevacizumab	NN	14132	14143
2497	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	for	IN	14144	14147
2498	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	the	DT	14148	14151
2499	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	treatment	NN	14152	14161
2500	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	of	IN	14162	14164
2501	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	cystic	JJ	14165	14171
2502	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	ACP	NNP	14172	14175
2503	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	in	IN	14176	14178
2504	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	pediatric	JJ	14179	14188
2505	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	patients	NNS	14189	14197
2506	PMC6712354.nxml.gz	PMC6712354.nxml.gz_107	14047	14198	.	.	14197	14198
2507	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	The	DT	14199	14202
2508	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	biological	JJ	14203	14213
2509	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	basis	NN	14214	14219
2510	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	for	IN	14220	14223
2511	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	this	DT	14224	14228
2512	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	was	VBD	14229	14232
2513	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	based	VBN	14233	14238
2514	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	on	IN	14239	14241
2515	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	recent	JJ	14242	14248
2516	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	studies	NNS	14249	14256
2517	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	that	WDT	14257	14261
2518	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	demonstrated	VBD	14262	14274
2519	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	elevated	VBD	14275	14283
2520	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	IL	NNP	14284	14286
2521	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	-	:	14286	14287
2522	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	6R	CD	14287	14289
2523	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	levels	NNS	14290	14296
2524	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	and	CC	14297	14300
2525	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	IL	NNP	14301	14303
2526	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	-	:	14303	14304
2527	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	6	CD	14304	14305
2528	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	transcript	NN	14306	14316
2529	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	levels	NNS	14317	14323
2530	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	in	IN	14324	14326
2531	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	ACP	NNP	14327	14330
2532	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	cyst	NN	14331	14335
2533	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	fluid	NN	14336	14341
2534	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	and	CC	14342	14345
2535	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	solid	JJ	14346	14351
2536	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	tissue	NN	14352	14358
2537	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	,	,	14358	14359
2538	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	respectively	RB	14360	14372
2539	PMC6712354.nxml.gz	PMC6712354.nxml.gz_108	14199	14373	.	.	14372	14373
2540	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	The	DT	14374	14377
2541	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	patient	NN	14378	14385
2542	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	in	IN	14386	14388
2543	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	case	NN	14389	14393
2544	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	1	CD	14394	14395
2545	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	had	VBD	14396	14399
2546	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	known	VBN	14400	14405
2547	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	elevated	VBN	14406	14414
2548	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	IL	NNP	14415	14417
2549	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	-	:	14417	14418
2550	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	6	CD	14418	14419
2551	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	in	IN	14420	14422
2552	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	cyst	NN	14423	14427
2553	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	fluid	NN	14428	14433
2554	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	prior	RB	14434	14439
2555	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	to	TO	14440	14442
2556	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	therapy	VB	14443	14450
2557	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	with	IN	14451	14455
2558	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	tocilizumab	NN	14456	14467
2559	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	and	CC	14468	14471
2560	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	level	NN	14472	14477
2561	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	were	VBD	14478	14482
2562	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	in	IN	14483	14485
2563	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	line	NN	14486	14490
2564	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	with	IN	14491	14495
2565	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	other	JJ	14496	14501
2566	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	samples	NNS	14502	14509
2567	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	tested	VBN	14510	14516
2568	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	(	(	14517	14518
2569	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	Figure	NNP	14518	14524
2570	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	3	CD	14525	14526
2571	PMC6712354.nxml.gz	PMC6712354.nxml.gz_109	14374	14528	).	NN	14526	14528
2572	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	Case	NNP	14529	14533
2573	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	2	CD	14534	14535
2574	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	had	VBD	14536	14539
2575	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	confirmation	NN	14540	14552
2576	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	of	IN	14553	14555
2577	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	elevated	JJ	14556	14564
2578	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	IL	NNP	14565	14567
2579	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	-	:	14567	14568
2580	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	6	CD	14568	14569
2581	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	in	IN	14570	14572
2582	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	pre	JJ	14573	14576
2583	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	-	:	14576	14577
2584	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	therapy	NN	14577	14584
2585	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	cyst	NN	14585	14589
2586	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	fluid	NN	14590	14595
2587	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	after	IN	14596	14601
2588	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	initiation	NN	14602	14612
2589	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	of	IN	14613	14615
2590	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	therapy	NN	14616	14623
2591	PMC6712354.nxml.gz	PMC6712354.nxml.gz_110	14529	14624	.	.	14623	14624
2592	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	In	IN	14625	14627
2593	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	addition	NN	14628	14636
2594	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	,	,	14636	14637
2595	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	genetically	RB	14638	14649
2596	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	engineered	VBN	14650	14660
2597	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	mouse	NN	14661	14666
2598	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	models	NNS	14667	14673
2599	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	of	IN	14674	14676
2600	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	ACP	NNP	14677	14680
2601	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	induced	VBN	14681	14688
2602	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	by	IN	14689	14691
2603	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	mutation	NN	14692	14700
2604	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	in	IN	14701	14703
2605	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	anterior	JJ	14704	14712
2606	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	pituitary	JJ	14713	14722
2607	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	progenitors	NNS	14723	14734
2608	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	faithfully	RB	14735	14745
2609	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	recapitulate	VBP	14746	14758
2610	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	many	JJ	14759	14763
2611	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	histological	JJ	14764	14776
2612	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	and	CC	14777	14780
2613	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	biological	JJ	14781	14791
2614	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	characteristics	NNS	14792	14807
2615	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	of	IN	14808	14810
2616	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	human	JJ	14811	14816
2617	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	ACP	NNP	14817	14820
2618	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	implying	NN	14821	14829
2619	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	that	IN	14830	14834
2620	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	the	DT	14835	14838
2621	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	tumor	NN	14839	14844
2622	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	may	MD	14845	14848
2623	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	arise	VB	14849	14854
2624	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	from	IN	14855	14859
2625	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	tissue	NN	14860	14866
2626	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	that	IN	14867	14871
2627	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	lacks	VBZ	14872	14877
2628	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	blood	NN	14878	14883
2629	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	-	:	14883	14884
2630	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	brain	NN	14884	14889
2631	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	barrier	NN	14890	14897
2632	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	protection	NN	14898	14908
2633	PMC6712354.nxml.gz	PMC6712354.nxml.gz_111	14625	14909	.	.	14908	14909
2634	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	Thus	RB	14910	14914
2635	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	,	,	14914	14915
2636	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	systemically	RB	14916	14928
2637	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	administered	VBN	14929	14941
2638	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	therapy	NN	14942	14949
2639	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	may	MD	14950	14953
2640	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	achieve	VB	14954	14961
2641	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	sufficient	JJ	14962	14972
2642	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	tissue	NN	14973	14979
2643	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	levels	NNS	14980	14986
2644	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	at	IN	14987	14989
2645	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	the	DT	14990	14993
2646	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	site	NN	14994	14998
2647	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	of	IN	14999	15001
2648	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	the	DT	15002	15005
2649	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	lesion	NN	15006	15012
2650	PMC6712354.nxml.gz	PMC6712354.nxml.gz_112	14910	15013	.	.	15012	15013
2651	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	In	IN	15014	15016
2652	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	both	DT	15017	15021
2653	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	cases	NNS	15022	15027
2654	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	presented	VBN	15028	15037
2655	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	,	,	15037	15038
2656	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	the	DT	15039	15042
2657	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	cystic	JJ	15043	15049
2658	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	portion	NN	15050	15057
2659	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	of	IN	15058	15060
2660	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	tumor	NN	15061	15066
2661	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	responded	VBD	15067	15076
2662	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	,	,	15076	15077
2663	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	further	RBR	15078	15085
2664	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	supporting	VBG	15086	15096
2665	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	the	DT	15097	15100
2666	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	potential	JJ	15101	15110
2667	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	relevance	NN	15111	15120
2668	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	of	IN	15121	15123
2669	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	this	DT	15124	15128
2670	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	therapy	NN	15129	15136
2671	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	in	IN	15137	15139
2672	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	children	NNS	15140	15148
2673	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	with	IN	15149	15153
2674	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	cystic	JJ	15154	15160
2675	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	ACP	NNP	15161	15164
2676	PMC6712354.nxml.gz	PMC6712354.nxml.gz_113	15014	15165	.	.	15164	15165
2677	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	Caption	NNP	15167	15174
2678	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	(	(	15175	15176
2679	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	Fig	NNP	15176	15179
2680	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	):	NNP	15179	15181
2681	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	FIG	NNP	15182	15185
2682	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	3	CD	15186	15187
2683	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	IL	NNP	15189	15191
2684	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	-	:	15191	15192
2685	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	6	CD	15192	15193
2686	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	Levels	NNS	15194	15200
2687	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	at	IN	15201	15203
2688	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	diagnosis	NN	15204	15213
2689	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	for	IN	15214	15217
2690	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	patient	JJ	15218	15225
2691	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	1	CD	15226	15227
2692	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	,	,	15227	15228
2693	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	patient	NN	15229	15236
2694	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	2	CD	15237	15238
2695	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	,	,	15238	15239
2696	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	a	DT	15240	15241
2697	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	group	NN	15242	15247
2698	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	of	IN	15248	15250
2699	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	ACP	NNP	15251	15254
2700	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	Patients	NNP	15255	15263
2701	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	,	,	15263	15264
2702	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	and	CC	15265	15268
2703	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	a	DT	15269	15270
2704	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	group	NN	15271	15276
2705	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	of	IN	15277	15279
2706	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	pilocytic	JJ	15280	15289
2707	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	astrocytoma	NN	15290	15301
2708	PMC6712354.nxml.gz	PMC6712354.nxml.gz_114	15167	15302	.	.	15301	15302
2709	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	The	DT	15303	15306
2710	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	IL	NNP	15307	15309
2711	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	-	:	15309	15310
2712	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	6	CD	15310	15311
2713	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	levels	NNS	15312	15318
2714	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	(	(	15319	15320
2715	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	pg	NN	15320	15322
2716	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	/	NNP	15322	15323
2717	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	mL	NN	15323	15325
2718	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	)	)	15325	15326
2719	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	found	VBD	15327	15332
2720	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	in	IN	15333	15335
2721	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	the	DT	15336	15339
2722	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	cystic	JJ	15340	15346
2723	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	fluid	NN	15347	15352
2724	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	of	IN	15353	15355
2725	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	patient	JJ	15356	15363
2726	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	1	CD	15364	15365
2727	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	and	CC	15366	15369
2728	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	patient	JJ	15370	15377
2729	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	2	CD	15378	15379
2730	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	at	IN	15380	15382
2731	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	diagnosis	NN	15383	15392
2732	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	as	RB	15393	15395
2733	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	well	RB	15396	15400
2734	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	as	IN	15401	15403
2735	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	a	DT	15404	15405
2736	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	group	NN	15406	15411
2737	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	of	IN	15412	15414
2738	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	6	CD	15415	15416
2739	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	craniopharyngioma	NN	15417	15434
2740	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	patients	NNS	15435	15443
2741	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	and	CC	15444	15447
2742	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	a	DT	15448	15449
2743	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	group	NN	15450	15455
2744	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	of	IN	15456	15458
2745	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	5	CD	15459	15460
2746	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	patients	NNS	15461	15469
2747	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	with	IN	15470	15474
2748	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	pilocytic	JJ	15475	15484
2749	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	astrocytoma	NN	15485	15496
2750	PMC6712354.nxml.gz	PMC6712354.nxml.gz_115	15303	15497	.	.	15496	15497
2751	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	Current	JJ	15499	15506
2752	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	therapies	NNS	15507	15516
2753	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	for	IN	15517	15520
2754	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	pediatric	JJ	15521	15530
2755	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	ACP	NNP	15531	15534
2756	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	can	MD	15535	15538
2757	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	cause	VB	15539	15544
2758	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	significant	JJ	15545	15556
2759	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	morbidity	NN	15557	15566
2760	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	,	,	15566	15567
2761	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	and	CC	15568	15571
2762	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	safer	JJR	15572	15577
2763	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	,	,	15577	15578
2764	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	more	RBR	15579	15583
2765	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	effective	JJ	15584	15593
2766	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	treatment	NN	15594	15603
2767	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	is	VBZ	15604	15606
2768	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	needed	VBN	15607	15613
2769	PMC6712354.nxml.gz	PMC6712354.nxml.gz_116	15499	15614	.	.	15613	15614
2770	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	Research	NN	15615	15623
2771	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	is	VBZ	15624	15626
2772	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	expanding	VBG	15627	15636
2773	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	these	DT	15637	15642
2774	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	options	NNS	15643	15650
2775	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	to	TO	15651	15653
2776	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	include	VB	15654	15661
2777	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	a	DT	15662	15663
2778	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	number	NN	15664	15670
2779	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	of	IN	15671	15673
2780	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	biologic	JJ	15674	15682
2781	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	approaches	NNS	15683	15693
2782	PMC6712354.nxml.gz	PMC6712354.nxml.gz_117	15615	15694	.	.	15693	15694
2783	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	This	DT	15695	15699
2784	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	includes	VBZ	15700	15708
2785	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	the	DT	15709	15712
2786	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	potential	JJ	15713	15722
2787	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	to	TO	15723	15725
2788	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	target	VB	15726	15732
2789	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	beta	SYM	15733	15737
2790	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	-	:	15737	15738
2791	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	catenin	NN	15738	15745
2792	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	and	CC	15746	15749
2793	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	the	DT	15750	15753
2794	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	use	NN	15754	15757
2795	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	of	IN	15758	15760
2796	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	MEK	NNP	15761	15764
2797	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	inhibitors	NNS	15765	15775
2798	PMC6712354.nxml.gz	PMC6712354.nxml.gz_118	15695	15776	.	.	15775	15776
2799	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	Here	RB	15777	15781
2800	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	we	PRP	15782	15784
2801	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	propose	VBP	15785	15792
2802	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	new	JJ	15793	15796
2803	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	potential	JJ	15797	15806
2804	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	agents	NNS	15807	15813
2805	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	,	,	15813	15814
2806	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	tocilizumab	VB	15815	15826
2807	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	alone	RB	15827	15832
2808	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	or	CC	15833	15835
2809	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	in	IN	15836	15838
2810	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	combination	NN	15839	15850
2811	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	with	IN	15851	15855
2812	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	bevacizumab	NN	15856	15867
2813	PMC6712354.nxml.gz	PMC6712354.nxml.gz_119	15777	15868	.	.	15867	15868
2814	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	Since	IN	15869	15874
2815	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	Patient	NNP	15875	15882
2816	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	1	CD	15883	15884
2817	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	progressed	VBD	15885	15895
2818	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	on	IN	15896	15898
2819	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	tocilizumab	NN	15899	15910
2820	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	alone	RB	15911	15916
2821	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	,	,	15916	15917
2822	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	bevacizumab	NN	15918	15929
2823	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	was	VBD	15930	15933
2824	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	added	VBN	15934	15939
2825	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	as	IN	15940	15942
2826	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	a	DT	15943	15944
2827	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	cyst	NN	15945	15949
2828	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	targeted	VBN	15950	15958
2829	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	therapy	NN	15959	15966
2830	PMC6712354.nxml.gz	PMC6712354.nxml.gz_120	15869	15967	.	.	15966	15967
2831	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	Bevacizumab	NNP	15968	15979
2832	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	,	,	15979	15980
2833	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	a	DT	15981	15982
2834	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	monoclonal	JJ	15983	15993
2835	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	antibody	NN	15994	16002
2836	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	that	WDT	16003	16007
2837	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	binds	VBZ	16008	16013
2838	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	to	TO	16014	16016
2839	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	vascular	VB	16017	16025
2840	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	endothelial	JJ	16026	16037
2841	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	growth	NN	16038	16044
2842	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	factor	NN	16045	16051
2843	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	(	(	16052	16053
2844	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	VEGF	NNP	16053	16057
2845	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	)	)	16057	16058
2846	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	resulting	VBG	16059	16068
2847	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	in	IN	16069	16071
2848	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	inhibition	NN	16072	16082
2849	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	of	IN	16083	16085
2850	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	new	JJ	16086	16089
2851	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	blood	NN	16090	16095
2852	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	vessel	NN	16096	16102
2853	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	formation	NN	16103	16112
2854	PMC6712354.nxml.gz	PMC6712354.nxml.gz_121	15968	16113	.	.	16112	16113
2855	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	No	DT	16114	16116
2856	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	research	NN	16117	16125
2857	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	has	VBZ	16126	16129
2858	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	been	VBN	16130	16134
2859	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	done	VBN	16135	16139
2860	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	on	IN	16140	16142
2861	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	the	DT	16143	16146
2862	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	use	NN	16147	16150
2863	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	of	IN	16151	16153
2864	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	bevacizumab	NN	16154	16165
2865	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	in	IN	16166	16168
2866	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	ACP	NNP	16169	16172
2867	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	patients	NNS	16173	16181
2868	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	,	,	16181	16182
2869	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	but	CC	16183	16186
2870	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	one	CD	16187	16190
2871	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	small	JJ	16191	16196
2872	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	case	NN	16197	16201
2873	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	series	NN	16202	16208
2874	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	reviewed	VBD	16209	16217
2875	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	the	DT	16218	16221
2876	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	use	NN	16222	16225
2877	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	of	IN	16226	16228
2878	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	bevacizumab	NN	16229	16240
2879	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	in	IN	16241	16243
2880	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	three	CD	16244	16249
2881	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	patients	NNS	16250	16258
2882	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	with	IN	16259	16263
2883	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	pilocytic	JJ	16264	16273
2884	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	astrocytoma	NN	16274	16285
2885	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	(	(	16286	16287
2886	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	PA	NNP	16287	16289
2887	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	),	NNP	16289	16291
2888	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	another	DT	16292	16299
2889	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	predominantly	RB	16300	16313
2890	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	cystic	JJ	16314	16320
2891	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	tumor	NN	16321	16326
2892	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	,	,	16326	16327
2893	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	and	CC	16328	16331
2894	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	found	VBD	16332	16337
2895	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	that	IN	16338	16342
2896	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	all	DT	16343	16346
2897	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	three	CD	16347	16352
2898	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	patients	NNS	16353	16361
2899	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	tolerated	VBD	16362	16371
2900	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	the	DT	16372	16375
2901	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	therapy	NN	16376	16383
2902	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	well	RB	16384	16388
2903	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	and	CC	16389	16392
2904	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	resulted	VBD	16393	16401
2905	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	in	IN	16402	16404
2906	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	a	DT	16405	16406
2907	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	decrease	NN	16407	16415
2908	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	cyst	NN	16416	16420
2909	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	volumes	NNS	16421	16428
2910	PMC6712354.nxml.gz	PMC6712354.nxml.gz_122	16114	16429	.	.	16428	16429
2911	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	Bevacizumab	NNP	16430	16441
2912	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	has	VBZ	16442	16445
2913	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	also	RB	16446	16450
2914	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	been	VBN	16451	16455
2915	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	shown	VBN	16456	16461
2916	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	recently	RB	16462	16470
2917	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	to	TO	16471	16473
2918	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	have	VB	16474	16478
2919	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	clinical	JJ	16479	16487
2920	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	and	CC	16488	16491
2921	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	radiographic	JJ	16492	16504
2922	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	effects	NNS	16505	16512
2923	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	in	IN	16513	16515
2924	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	adult	NN	16516	16521
2925	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	PA	NNP	16522	16524
2926	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	patients	NNS	16525	16533
2927	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	and	CC	16534	16537
2928	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	has	VBZ	16538	16541
2929	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	been	VBN	16542	16546
2930	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	shown	VBN	16547	16552
2931	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	to	TO	16553	16555
2932	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	be	VB	16556	16558
2933	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	a	DT	16559	16560
2934	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	safe	JJ	16561	16565
2935	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	and	CC	16566	16569
2936	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	tolerated	JJ	16570	16579
2937	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	therapy	NN	16580	16587
2938	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	in	IN	16588	16590
2939	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	pediatric	JJ	16591	16600
2940	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	patients	NNS	16601	16609
2941	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	with	IN	16610	16614
2942	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	PA	NNP	16615	16617
2943	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	and	CC	16618	16621
2944	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	other	JJ	16622	16627
2945	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	forms	NNS	16628	16633
2946	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	of	IN	16634	16636
2947	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	low	JJ	16637	16640
2948	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	-	:	16640	16641
2949	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	grade	NN	16641	16646
2950	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	glioma	NN	16647	16653
2951	PMC6712354.nxml.gz	PMC6712354.nxml.gz_123	16430	16654	.	.	16653	16654
2952	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	Overall	JJ	16655	16662
2953	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	,	,	16662	16663
2954	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	the	DT	16664	16667
2955	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	patients	NNS	16668	16676
2956	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	presented	VBN	16677	16686
2957	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	tolerated	JJ	16687	16696
2958	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	therapy	NN	16697	16704
2959	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	well	RB	16705	16709
2960	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	without	IN	16710	16717
2961	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	significant	JJ	16718	16729
2962	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	side	NN	16730	16734
2963	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	effects	NNS	16735	16742
2964	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	or	CC	16743	16745
2965	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	complications	NNS	16746	16759
2966	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	other	JJ	16760	16765
2967	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	than	IN	16766	16770
2968	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	isolated	JJ	16771	16779
2969	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	Grade	NNP	16780	16785
2970	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	3	CD	16786	16787
2971	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	neutropenia	NN	16788	16799
2972	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	without	IN	16800	16807
2973	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	associated	JJ	16808	16818
2974	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	infections	NNS	16819	16829
2975	PMC6712354.nxml.gz	PMC6712354.nxml.gz_124	16655	16830	.	.	16829	16830
2976	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	These	DT	16832	16837
2977	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	two	CD	16838	16841
2978	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	case	NN	16842	16846
2979	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	studies	NNS	16847	16854
2980	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	suggest	VBP	16855	16862
2981	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	that	IN	16863	16867
2982	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	the	DT	16868	16871
2983	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	combination	NN	16872	16883
2984	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	use	NN	16884	16887
2985	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	of	IN	16888	16890
2986	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	systemically	RB	16891	16903
2987	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	administered	VBN	16904	16916
2988	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	tocilizumab	NN	16917	16928
2989	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	and	CC	16929	16932
2990	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	bevacizumab	NN	16933	16944
2991	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	may	MD	16945	16948
2992	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	be	VB	16949	16951
2993	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	effective	JJ	16952	16961
2994	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	in	IN	16962	16964
2995	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	pediatric	JJ	16965	16974
2996	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	patients	NNS	16975	16983
2997	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	with	IN	16984	16988
2998	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	primarily	RB	16989	16998
2999	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	cystic	JJ	16999	17005
3000	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	craniopharyngioma	NN	17006	17023
3001	PMC6712354.nxml.gz	PMC6712354.nxml.gz_125	16832	17024	.	.	17023	17024
3002	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	Future	JJ	17025	17031
3003	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	evaluation	NN	17032	17042
3004	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	of	IN	17043	17045
3005	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	this	DT	17046	17050
3006	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	combination	NN	17051	17062
3007	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	of	IN	17063	17065
3008	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	this	DT	17066	17070
3009	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	drug	NN	17071	17075
3010	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	is	VBZ	17076	17078
3011	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	needed	VBN	17079	17085
3012	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	to	TO	17086	17088
3013	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	further	RBR	17089	17096
3014	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	evaluate	VB	17097	17105
3015	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	the	DT	17106	17109
3016	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	potential	NN	17110	17119
3017	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	of	IN	17120	17122
3018	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	these	DT	17123	17128
3019	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	drugs	NNS	17129	17134
3020	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	in	IN	17135	17137
3021	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	the	DT	17138	17141
3022	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	management	NN	17142	17152
3023	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	of	IN	17153	17155
3024	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	ACP	NNP	17156	17159
3025	PMC6712354.nxml.gz	PMC6712354.nxml.gz_126	17025	17160	.	.	17159	17160
3026	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	Author	NN	17162	17168
3027	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	Contributions	NNP	17169	17182
3028	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	SG	NNP	17184	17186
3029	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	did	VBD	17187	17190
3030	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	primary	JJ	17191	17198
3031	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	case	NN	17199	17203
3032	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	reviews	NNS	17204	17211
3033	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	and	CC	17212	17215
3034	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	writing	VBG	17216	17223
3035	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	of	IN	17224	17226
3036	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	original	JJ	17227	17235
3037	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	draft	NN	17236	17241
3038	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	of	IN	17242	17244
3039	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	manuscript	NN	17245	17255
3040	PMC6712354.nxml.gz	PMC6712354.nxml.gz_127	17162	17256	.	.	17255	17256
3041	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	DM	NNP	17257	17259
3042	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	provided	VBD	17260	17268
3043	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	MRI	NNP	17269	17272
3044	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	analysis	NN	17273	17281
3045	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	and	CC	17282	17285
3046	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	figures	NNS	17286	17293
3047	PMC6712354.nxml.gz	PMC6712354.nxml.gz_128	17257	17294	.	.	17293	17294
3048	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	AD	NN	17295	17297
3049	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	and	CC	17298	17301
3050	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	NF	NNP	17302	17304
3051	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	provided	VBD	17305	17313
3052	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	laboratory	NN	17314	17324
3053	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	data	NNS	17325	17329
3054	PMC6712354.nxml.gz	PMC6712354.nxml.gz_129	17295	17330	.	.	17329	17330
3055	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	ND	NNP	17331	17333
3056	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	and	CC	17334	17337
3057	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	LH	NNP	17338	17340
3058	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	provided	VBD	17341	17349
3059	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	patient	JJ	17350	17357
3060	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	care	NN	17358	17362
3061	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	and	CC	17363	17366
3062	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	manuscript	NN	17367	17377
3063	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	preparation	NN	17378	17389
3064	PMC6712354.nxml.gz	PMC6712354.nxml.gz_130	17331	17390	.	.	17389	17390
3065	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	TH	NNP	17391	17393
3066	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	and	CC	17394	17397
3067	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	JM	NNP	17398	17400
3068	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	provided	VBD	17401	17409
3069	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	primary	JJ	17410	17417
3070	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	patient	NN	17418	17425
3071	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	care	NN	17426	17430
3072	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	,	,	17430	17431
3073	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	conceptualization	NN	17432	17449
3074	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	,	,	17449	17450
3075	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	manuscript	JJ	17451	17461
3076	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	preparation	NN	17462	17473
3077	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	,	,	17473	17474
3078	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	and	CC	17475	17478
3079	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	project	NN	17479	17486
3080	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	management	NN	17487	17497
3081	PMC6712354.nxml.gz	PMC6712354.nxml.gz_131	17391	17498	.	.	17497	17498
3082	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	Conflict	NN	17500	17508
3083	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	of	IN	17509	17511
3084	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	Interest	NNP	17512	17520
3085	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	Statement	NNP	17521	17530
3086	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	The	DT	17532	17535
3087	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	authors	NNS	17536	17543
3088	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	declare	VBP	17544	17551
3089	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	that	IN	17552	17556
3090	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	the	DT	17557	17560
3091	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	research	NN	17561	17569
3092	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	was	VBD	17570	17573
3093	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	conducted	VBN	17574	17583
3094	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	in	IN	17584	17586
3095	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	the	DT	17587	17590
3096	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	absence	NN	17591	17598
3097	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	of	IN	17599	17601
3098	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	any	DT	17602	17605
3099	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	commercial	JJ	17606	17616
3100	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	or	CC	17617	17619
3101	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	financial	JJ	17620	17629
3102	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	relationships	NNS	17630	17643
3103	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	that	WDT	17644	17648
3104	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	could	MD	17649	17654
3105	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	be	VB	17655	17657
3106	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	construed	VBN	17658	17667
3107	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	as	IN	17668	17670
3108	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	a	DT	17671	17672
3109	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	potential	JJ	17673	17682
3110	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	conflict	NN	17683	17691
3111	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	of	IN	17692	17694
3112	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	interest	NN	17695	17703
3113	PMC6712354.nxml.gz	PMC6712354.nxml.gz_132	17500	17704	.	.	17703	17704
3114	PMC6712354.nxml.gz	PMC6712354.nxml.gz_133	17706	17714	Funding	NN	17706	17713
3115	PMC6712354.nxml.gz	PMC6712354.nxml.gz_133	17706	17714	.	.	17713	17714
3116	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	The	DT	17715	17718
3117	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	Morgan	NNP	17719	17725
3118	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	Adams	NNP	17726	17731
3119	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	Foundation	NNP	17732	17742
3120	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	(	(	17743	17744
3121	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	SG	NNP	17744	17746
3122	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	,	,	17746	17747
3123	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	NF	NNP	17748	17750
3124	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	,	,	17750	17751
3125	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	LH	NNP	17752	17754
3126	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	,	,	17754	17755
3127	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	TH	NNP	17756	17758
3128	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	,	,	17758	17759
3129	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	and	CC	17760	17763
3130	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	JM	NNP	17764	17766
3131	PMC6712354.nxml.gz	PMC6712354.nxml.gz_134	17715	17768	).	NNP	17766	17768
3132	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	Additional	JJ	17769	17779
3133	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	funding	NN	17780	17787
3134	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	to	TO	17788	17790
3135	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	TH	NNP	17791	17793
3136	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	by	IN	17794	17796
3137	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	NCI	NNP	17797	17800
3138	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	R03	NNP	17801	17804
3139	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	CA235200	NNP	17805	17813
3140	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	,	,	17813	17814
3141	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	GN	NNP	17815	17817
3142	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	-	:	17817	17818
3143	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	000522â	CD	17818	17825
3144	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869		IN	17825	17827
3145	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	The	DT	17827	17830
3146	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	Brain	NNP	17831	17836
3147	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	Tumor	NNP	17837	17842
3148	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	Charity	NNP	17843	17850
3149	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	,	,	17850	17851
3150	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	NCI	NNP	17852	17855
3151	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	R03	NNP	17856	17859
3152	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	CA212800	NNP	17860	17868
3153	PMC6712354.nxml.gz	PMC6712354.nxml.gz_135	17769	17869	.	.	17868	17869
